НОВЫЕ ЛЕКАРСТВЕННЫЕ ФОРМЫ ЗАМЕЩЕННЫХ БЕНЗИМИДАЗОЛОВ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ

Описаны твердые фармацевтические композиции для лечения желудочно-кишечных нарушений. Композиция содержит в качестве ингибитора протонного насоса омепразол, по меньшей мере часть которого не покрыта энтеросолюбильной оболочкой, и бикарбонат натрия как буферизующий агент. Композиция выполнена в форме жевательной таблетки. Согласно второму варианту композиция содержит омепразол, по меньшей мере часть которого не покрыта энтеросолюбильной оболочкой, бикарбонат натрия как буферизующий агент, и по меньшей мере, один дезинтегрант и/или смазку. При оральном введении пациенту указанных фармацевтических композиций терапевтически эффективное количество омепразола напрямую всасывается через желудок пациента для немедленного и эффективного лечения нарушений, связанных с желудочной кислотой. Новые лекарственные формы омепразола удобны для приготовления и обеспечивают его быстрое всасывание, а также делают доступным препарат омепразол для определенной категории больных, неспособных проглатывать твердые ...

Лекарственный сбор с тонизирующим и адаптогенным действием

Изобретение относится к фармацевтической промышленности, а именно к лекарственному сбору с тонизирующим и адаптогенным действием. Лекарственный сбор с тонизирующим и адаптогенным действием, включающий плоды грецкого ореха, листья мяты перечной, плоды лимонника китайского и корневища с корнями левзеи сафлоровидной, в определенном соотношении компонентов. Вышеописанный сбор обладает выраженным тонизирующим и адаптогенным действием. 3 пр.

ВДЫХАЕМЫЕ СОСТАВЫ НА ОСНОВЕ НИКОТИНА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ

Группа изобретений относится к сухому порошкообразному составу для вдыхания для имитирования эффектов курения. Сухой порошкообразный состав на основе никотина, содержащий частицы, где частицы содержат: соль никотина, по меньшей мере один сахар, и по меньшей мере одну аминокислоту, выбранную из группы, состоящей из глицина, лизина, лейцина и их комбинации, где частицы имеют размер от 1 до 7 микрон, где концентрация никотина составляет от 0,5% до 10% по весу, и концентрация по меньшей мере одного сахара составляет от 50% до 99% по весу, и где состав является подходящим для вдыхания для имитирования эффектов курения. Сухой порошкообразный состав на основе никотина, состоящий из частиц, содержащих никотин, по меньшей мере один сахар, ментол и по меньшей мере одну аминокислоту, выбранную из группы, состоящей из глицина, лизина и лейцина, где частицы имеют размер от 1 до 7 микрон, где концентрация никотина составляет от 0,5% до 10% по весу, и концентрация по меньшей мере одного сахара составляет ...

ВДЫХАЕМЫЕ НИКОТИНОВЫЕ КОМПОЗИЦИИ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ

Изобретение относится к сухой порошковой никотиновой композиции, пригодной для ингаляции, причем композиция включает от 0,7 до 5% никотина, содержащего соль никотина, полученную из молочной кислоты, от 50 до 99% по меньшей мере одного сахара, содержащего трегалозу, и от 0,5 до 10% по меньшей мере одной аминокислоты. Технический результат заключается в обеспечении никотиносодержащей композиции для ингаляции. 3 н. и 20 з.п. ф-лы, 6 ил.

КОМПОЗИЦИИ И СПОСОБЫ ДЛЯ ИНГИБИРОВАНИЯ СЕКРЕЦИИ ЖЕЛУДОЧНОЙ КИСЛОТЫ С ИСПОЛЬЗОВАНИЕМ ПРОИЗВОДНЫХ МАЛЫХ ДИКАРБОНОВЫХ КИСЛОТ В СОЧЕТАНИИ С PPI

Настоящее изобретение относится к новым пероральным композициям, содержащим необратимый желудочный ингибитор Н/K-АТФазы протонной помпы (PPI) в качестве ингибитора секреции желудочной кислоты и одну или несколько молекул производных алифатических карбоновых кислот, которые активируют париетальные клетки, где производные вызывают отсроченный или длительный эффект усиления в отношении активности PPI по сравнению с немодифицированными молекулами кислоты. Настоящее изобретение дополнительно относится к способу применения таких композиций для снижения секреции желудочной кислоты у млекопитающего. 3 н. и 14 з.п. ф-лы, 3 пр., 2 ил.

ЛЕДЕНЦЫ ДЛЯ ПРОФИЛАКТИКИ ПОСТОПЕРАЦИОННЫХ ОСЛОЖНЕНИЙ У ДЕТЕЙ ПОСЛЕ УРАНОПЛАСТИКИ

Настоящее изобретение относится к области медицины, а именно к средству для профилактики постоперационных осложнений у детей после уранопластики, выполненное в виде леденцов, содержащих в качестве биологически активных веществ растительный экстракт и эфирное масло мяты перечной, а в качестве карамельной массы сорбит и воду очищенную, где в качестве растительного экстракта содержится густой экстракт полиэкстракта, содержащего полученный перколяцией при соотношении сырье:экстрагент 1:1 экстракт цветков календулы лекарственной, полученный с использованием 70% спирта этилового, и полученный мацерацией при соотношении сырье:экстрагент 1:10 водный экстракт сбора, содержащего цветки ромашки аптечной, листья мяты перечной и корни солодки голой, взятые в равном соотношении, при следующем соотношении исходных компонентов, г: густой экстракт полиэкстракта 5, эфирное масло мяты перечной 0,02, сорбит 100, вода очищенная 15. Настоящее изобретение обеспечивает оптимальные условия для заживления раны и ...

Седативное лекарственное средство в форме таблеток

Изобретение относится к области фармацевтики, в частности к препаратам, применяемым в качестве успокаивающего и сосудорасширяющего средства при функциональных расстройствах сердечно-сосудистой системы, неврозоподобных состояниях, сопровождающихся повышенной раздражительностью, при нарушении засыпания, тахикардии, состоянии возбуждения с выраженными вегетативными проявлениями, а также в качестве спазмолитического средства - при спазмах кишечника. Средство содержит мелиссы лекарственной листьев экстракт, мяты перечной масло, пустырника травы экстракт и вспомогательные вещества. Компоненты используются в заявленных количествах. Использование изобретения обеспечивает уменьшение побочных явлений и противопоказаний за счет исключения бромсодержащего соединения и уменьшения дозировки активных ингредиентов при сохранении терапевтической эффективности. 2 з.п. ф-лы, 2 табл., 10 пр.

Фитокомпозиция для гигиены полости рта

Изобретение относится к медицине, а именно к стоматологии, и может быть использовано для ухода за зубами и полостью рта, для гигиены полости рта, в частности, у онкологических больных. Фитокомпозиция для гигиены полости рта у онкологических больных, страдающих сопутствующими заболеваниями зубов и десен и прошедших химио- и лучевую терапию, характеризуется тем, что представляет собой порошок измельченных лекарственных растений: травы мяты перечной, травы череды, травы чистотела, цветов, листьев и стебля эхинацеи, травы тысячелистника, цветов календулы, цветов пижмы, цветов лабазника, корня аира, листа подорожника, взятые в равных соотношениях 1:1, при этом порошок получен методом дробного измельчения до частиц, проходящих сквозь сито 0,5 мм. Фитокомпозиция может быть выполнена в виде разовой дозы порошка массой 3 г. Порошок может применяться в виде водного настоя, который получают при заливании 3 г порошка 200 мл кипятка. Водный настой может применяться в виде порционных кубиков льда. Порошок ...

Фармацевтическая композиция противодиабетического действия в виде саше

Изобретение относится к химико-фармацевтической промышленности, медицине, фармакологии. Композиция противодиабетического действия содержит компоненты в г/саше (мас.%): гликлазид 0,06 (1,6), сухой экстракт травы галеги лекарственной 0,10 (2,6), сухой экстракт корня солодки 0,60 (16,0), сухой экстракт травы мяты перечной 0,30 (8,0), пектин яблочный 2,00 (53,2), гидроксиэтилцеллюлоза 0,50 (13,3), раствор коллидона К-30 в спирте этиловом 0,20 (5,3). Изобретение обеспечивает создание фармацевтической композиции противодиабетического действия комплексного состава, выполненной в виде саше, содержащей гликлазид и смягчающие его побочные действия сухие экстракты галеги лекарственной, корня солодки, мяты перечной. 3 табл., 3 пр.

Фармацевтическая композиция противодиабетического действия в твердой лекарственной форме в виде таблеток

Изобретение относится к химико-фармацевтической промышленности, а именно к производству средств противодиабетического действия. Предложена твердая дозированная лекарственная форма пролонгированного действия, выполненная в виде таблеток, с противодиабетической активностью, содержащая гликлазид и микрокапсулированные сухие экстракты галеги лекарственной, солодки голой и мяты перечной, а также полиэтиленгликоль 6000, при определенном соотношении компонентов. Предложенная лекарственная форма характеризуется пролонгированным высвобождением гликлазида и фармакологически активных веществ, содержащихся в сухих экстрактах, обеспечивает повышение эффективности и безопасности лечения сахарного диабета за счет контролирования скорости высвобождения гликлазида и поддержания равномерной концентрации его в крови, а также сглаживания побочных эффектов растительными компонентами композиции. 3 табл.

КОМБИНАЦИЯ КОМПОНЕНТОВ ДЛЯ УЛУЧШЕНИЯ ФИЗИЧЕСКИХ ПОКАЗАТЕЛЕЙ У ЛИЦ, ЗАНИМАЮЩИХСЯ ТЯЖЕЛЫМИ ФИЗИЧЕСКИМИ НАГРУЗКАМИ

Изобретение относится к фармацевтической промышленности и представляет собой композицию для поддержания и/или восстановления организма во время и/или после тяжелых физических нагрузок, содержащую L-таурин, L-лейцин, L-изолейцин, L-валин, экстракт листьев зеленого чая, йохимбин гидрохлорид, элеутерококка колючего корневищ и корней экстракт, левзеи сафлоровидной корневищ с корнями экстракт, родиолы розовой корневищ с корнями экстракт, экстракт кожуры горького апельсина, рибофлавина натрия фосфат, холина альфосцерат, пантотенат кальция, пиридоксина гидрохлорид, фолиевую кислоту, цианокобаламин, биотин, никотинамид, L-карнитин, бета-аланин, калия оротат, метилурацил, инозин, кофеин, экстракт листьев, соцветий и корневищ иван-чая, креатина моногидрат, L-тирозин, аскорбиновую кислоту, магний в форме бис-глицината, медь в форме бис-глицината, цинк в форме бис-глицината, L-глутамин, тиамина гидрохлорид, холекальциферол 5000 МЕ, кальция малат, натрия дигидрофосфат, альфа-токоферола ацетат, L-селенметионин ...

Фитокомплекс для профилактики развития игровой зависимости (варианты)

Изобретение относится к фармацевтической промышленности, а именно к фитокомлексам для приготовления настоя для профилактики развития игровой зависимости (варианты). Фитокомплекс для приготовления настоя для профилактики развития игровой зависимости, характеризующийся тем, что содержит цветы, лист и стебель кипрея, цветы красного клевера, корень аира, траву пустырника, цветки и листья таволги, траву мяты, лист березы, лист брусники, цветы бессмертника, цветы липы, корень алтея, корень элеутерококка, корень солодки, плоды шиповника, цветы зверобоя при следующем соотношении 5:3:2:2:1:2:2:2:2:2:2:1:2:2:2 соответственно, для возрастной категории от 7 до 14 лет. Фитокомплекс для приготовления настоя для профилактики развития игровой зависимости, характеризующийся тем, что содержит цветы, лист и стебель кипрея, цветы красного клевера, корень аира, траву пустырника, цветки и листья таволги, траву мяты, лист березы, цветы бессмертника, цветы липы, корень алтея, корень элеутерококка, корень левзеи ...

ПРЕПАРАТ ИЗ МАСЕЛ ДЛЯ КОРРЕКЦИИ СОСТАВА МИКРОБИОТЫ КИШЕЧНИКА В ФОРМЕ КАПСУЛЫ С КИШЕЧНОРАСТВОРИМОЙ ОБОЛОЧКОЙ

Изобретение относится к области химико-фармацевтической, нутрицевтической промышленности и медицины и касается средства, корректирующего нарушения функционирования микробиоты. Препарат для коррекции состава микробиоты кишечника в форме мягкой капсулы, характеризующийся тем, что содержит оболочку, включающую желатин пищевой, глицерин, альгинат натрия, гидроксипропилметилцеллюлозу, стеариновую кислоту и аммония гидроксид, в которую заключено действующее начало в виде комплекса из масла листьев мяты перечной, эфирного масла корневищ имбиря, токоферола или смеси токоферолов, а также масла, выбранного из оливкового масла рафинированного, масла периллы или их смеси, при следующем содержании компонентов в мг на капсулу: желатин пищевой 110-130, глицерин 43-50, гидроксипропилметилцеллюлоза 22,5-27,5, альгинат натрия 4,7-5,3, аммония гидроксид 0,9-1,1, стеариновая кислота 0,3-0,7, эфирное масло корневищ имбиря 10-500, мяты перечной листьев масло 10-500, токоферол или смесь токоферолов 0,04-0,06, ...

ОРГАНОЛЕПТИЧЕСКИ ПРИЕМЛЕМЫЕ ПЕРОРАЛЬНЫЕ ЛЕКАРСТВЕННЫЕ ФОРМЫ ИБУПРОФЕНА, СПОСОБЫ ИХ ПРИГОТОВЛЕНИЯ И ПРИМЕНЕНИЯ

... 1. Органолептически приемлемая твердая пероральная дозированная лекарственная форма ибупрофена, содержащая: ! ибупрофен; и ! маскирующее средство, ! причем упомянутая лекарственная форма не включает циклодекстрин в количестве, превышающем количество ибупрофена в лекарственной форме в два или более раз. ! 2. Лекарственная форма по п.1, отличающаяся тем, что упомянутое маскирующее средство включает освежающее средство. ! 3. Лекарственная форма по п.2, отличающаяся тем, что упомянутое освежающее средство выбрано из группы, в которую входят L-ментол, DL-ментол, WS-23 (N,2,3-триметил-2-изопропилбутамид), WS-3 (N-этил-3-метил-2-(1-метилэтил)циклогексанкарбоксамид), масло мяты перечной и масло мяты курчавой. ! 4. Лекарственная форма по п.1, отличающаяся тем, что упомянутое маскирующее средство включает органическую кислоту. ! 5. Лекарственная форма по п.4, отличающаяся тем, что упомянутая органическая кислота выбрана из группы, в которую входят аспарагиновая кислота, лимонная кислота, яблочная ...

НИКОТИНОВЫЕ СОСТАВЫ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ

СПОСОБ ИЗГОТОВЛЕНИЯ ИЗДЕЛИЙ РАСТИТЕЛЬНОГО ПРОИСХОЖДЕНИЯ, ИМПРЕГНИРОВАННЫХ ЖИДКИМ РАСТИТЕЛЬНЫМ ВЕЩЕСТВОМ

... 1. Способ изготовления изделий, импрегнированных по меньшей мере одним растительным веществом из по меньшей мере одного растения, отличающийся тем, что он включает следующие стадии:a) экстракция и/или прессование по меньшей мере одного растения (Р1) или по меньшей мере одной части указанного растения, получая жидкий растительный экстракт (Э1) и твердый волокнистый остаток (О1), затемb) отделение указанного растительного экстракта (Э1) от указанного твердого волокнистого остатка (01), иc) деструктурирование указанного волокнистого остатка (О1),d) изготовление волокнистого полотна или формованного изделия из волокнистого остатка (01), полученного на стадии с), иe) импрегнирование указанного волокнистого остатка (О1) (i) по меньшей мере указанным растительным экстрактом (Э1), необязательно концентрированным, очищенным, ароматизированным и/или содержащим отдушки, (ii) по меньшей мере одним водорастворимым или жирорастворимым растительным веществом, выделенным из указанного растительного экстракта ...

МЯТЫ ПЕРЕЧНОЙ НАСТОЙКА И СПОСОБ ЕЕ ПОЛУЧЕНИЯ

ВДЫХАЕМЫЕ НИКОТИНОВЫЕ КОМПОЗИЦИИ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ

СПОСОБ КОЛИЧЕСТВЕННОГО ОПРЕДЕЛЕНИЯ РОЗМАРИНОВОЙ КИСЛОТЫ В ЛИСТЬЯХ МЯТЫ ПЕРЕЧНОЙ

Изобретение относится к области химико-фармацевтической промышленности, а именно к способу количественного определения содержания розмариновой кислоты в листьях мяты перечной. Способ осуществляют путем экстракции сырья органическими растворителями с последующей пробоподготовкой и определением оптической плотности методом ВЭЖХ, при этом экстракцию сырья осуществляют этиловым спиртом в концентрации 60% в соотношении «сырье-экстрагент» - 1:50, время экстракции – извлечение на кипящей водяной бане в течение 60 мин, степень измельчения сырья – 2 мм; количественное определение розмариновой кислоты в листьях мяты перечной проводят при длине волны 330 нм; содержание розмариновой кислоты X в процентах в абсолютно сухом сырье вычисляют по формуле: где H – среднее значение высоты пика розмариновой кислоты испытуемого раствора, вычисленное из хроматограмм раствора испытуемого образца; H0 – среднее значение высоты пика раствора СО розмариновой кислоты, вычисленное из хроматограмм раствора РСО розмариновой ...

Medicine for treating a disease which occur internally e.g. symptoms of inflammation of the stomach and for treating a disease occurring externally e.g. nail fungal infections

Medicine for treating a disease which occur internally e.g. symptoms of inflammation of the stomach and for treating a disease occurring externally e.g. nail fungal infections, is claimed. ACTIVITY : Antiinflammatory; Fungicide. No biological data given. MECHANISM OF ACTION : None given.

ABFUEHRMITTEL AUF DER BASIS VON PLANTAGOSAMEN UND SENNAFRUECHTEN UND VERFAHREN ZUR HERSTELLUNG DESSELBEN

ARZNEIMITTELZUBEREITUNG ZUR BEHANDLUNG VON MASTITIS BEI TIER UND MENSCH.

Mittel zum Auftragen auf eine überwärmte Körperregion

NEUE DOSISFORMEN VON SUBSTITUIERTEN BENZIMIDAZOLEN UND VERFAHREN ZUR DEREN VERWENDUNG

EIN MEDIZINISCHES PFLASTER ZUR BEHANDLUNG VON RHEUMA

Die vorliegende Erfindung offenbart ein medizinisches Pflaster zur Behandlung von Rheuma, das nach Gewichtsanteilen die folgenden Rohmaterialien umfasst: Radix Paeoniae Alba 30-40; Pfeffer 20-30; Folium artemisiae argyi 15-20; Radix Notoginseng 10-15 und Minzöl 3-7. Das medizinische Pflaster zur Behandlung von Rheuma wird durch die folgenden Schritte hergestellt: Mischen aller obigen Rohmaterialien, um eine Mischung zu erhalten, und Zerkleinern der Mischung unter Zugabe von Wasser, um eine Paste zu erhalten; Abkochen der Paste mit Wasser unter leichtem Feuer für 50-70 Min, wobei das Wasser in geeigneter Menge vorhanden ist, so dass der Zustand der Paste erhalten bleibt; und Abkühlen der obigen heißen Paste, um eine abgekühlte medizinische Paste zu erhalten, und Auftragen der abgekühlten medizinischen Paste auf ein medizinisches Pflastertuch zur Behandlung von Rheuma.

An Improvement in Cough Mixture for the Cure of Cough and Colds and for Bronchitis in its Early Stages.

... 29,543. Sinclair, E. J. C. Dec. 20. Medicines for internal use.-A cough mixture consists of a syrup of sugar and molasses, oil of peppermint, oil of aniseed, paregoric, ipecacuanha wine, and laudanum.

Compositions containing fructose and plant extracts

Compositions containing an extract of puerariae radix, phaseoli radiati semen, small red bean, crataegi fructus, malt, cnidii rhizoma, atractylodes rhizoma, cassiae semen, amomi semen and menthae folium plus fructose have activity in prophylaxis and treatment of the after effects of excessive alcohol intake.

Anti-snoring treatment

An anti-snoring treatment comprises the use of a water-based gargle before retiring to sleep. The gargle is prepared by adding a few drops of an emulsion containing oil of sage and oil of eucalyptus to warm water. The emulsion may also contain oils from fennel, dwarf pine, peppermint, lemon, lavender, cloves, thyme, balm and/or mastic.

Compositions for intranasal administration

The present invention relates to pharmaceutical compositions for administration to the nasal tract. In particular, the invention relates to dry powder compositions comprising cellulose, and in particular hyroxypropylmethylcellulose (HPMC), and one or more therapeutic agents. It has been shown that administration of HPMC to the nasal cavity is capable of enhancing natural mucus. These powders, and the gel that forms when they are administered to the nasal tract, have now surprisingly been found to be a very effective way of intranasally administering therapeutic agents, and in particular, herbal or homeopathic agents.

BETEL NUT AND NICOTINE CHEWING GUM

A gum based chewing product, particularly a chewing or bubble gum, containing a synthetic or natural betel nut source, and nicotine. Each gum piece may contain between 1 and 12.6 mg of nicotine. The product may contain taste enhancers such as catechu and lime. A process for the preparation of the gum is also outlined.

Antimicrobial composition

Compositions for the preservation of foodstuffs, for the sterilization and hygiene ofair in confined spaces and for cosmetic and pharmaceutical purposes

A composition for the preservation of foodstuffs, for the sterilization of air in confined spaces and for cosmetic and pharmaceutical purposes comprising an essential oil having bacteriostatic and/or bactericidal properties or a bacteriostatically and/or bactericidally active compound extracted from such an oil, acetic or citric acid and ethanol or ispropyl alcohol. The composition may comprise oil of cloves, cinnamon oil, peppermint oil, oil of thyme, oil of rosemary, mustard oil, thymol, cinnamic aldehyde, polyoxyethylene oleate or stearate, polyoxyethylene sorbitan mono-palmitate, mono- or tri-oleate, or mono- or tri-stearate, and mucilages of animal, vegetable or synthetic origin (e.g. tragacanth or agar-agar). The composition may be in the form of an aqueous concentrate. The composition may be applied to the food by steeping or spraying. Sheep's guts, pigs' intestines, fish, shellfish, sausages, cheese and pastry goods may be treated. The composition may be sprayed or vapourized in ...

Gum based chewing product and process for preparing the same

A composition for oral administration

Preparation of a drug for the treatment of rheumatism and the opportunist diseases containing the natural plants.

COMPOSITION TO THE PROTECTION AND FOR THE REGENERATION OF LIVER STRUCTURE AND FUNCTION

PROCEDURE FOR THE PRODUCTION OF AN EXHAUSTING MEANS ON THE BASIS OF PLANTAGOSAMEN AND SENNAFRUECHTEN

PETASINFREIE POLAR ONES PETASITESEXTRAKTFRAKTIONEN AND THEIR USE FOR PAIN TREATMENT

PHARMACEUTICAL ONE ZUSAMMENETZUNG CONTAINING A GASTRIC ACID CONNECTION AND/OR A NEUTRALIZING ACTIVE SUBSTANCE AS ALGINSÄUREDERIVAT

EYE DROP

COMPOSITION

Die vorliegende Erfindung betrifft eine Zusammensetzung umfassend Olivenöl und mindestens drei ätherische Öle ausgewählt aus der Gruppe bestehend aus Zitronenöl, Pfefferminzöl, Eukalyptusöl und Lavendelöl.

, CONTAINING TO CHEWING RUBBER COMPOSITION FOR THE REMOVAL OF NICOTINE PLANZENEXTRAKTEN

PROCEDURE FOR THE PRODUCTION OF THE ACTIVE SUBSTANCES FROM VEGETABLE DRUGS

COMBINATION OF ARNICA, RUSCUS AND MENTHOL

ANTI-PARASITIC MEANS

PYRROLIZIDINALKALOIDFREIE PETASITES CONTAINING COMPOSITION

AT LEAST A IN VITRO LABIATE OF THE KIND CULTIVATED USE OF AN EXCERPT ROSMARINARUS IN A COMPOSITION

COMPOSITION FOR THE TREATMENT OF EVIL-SMELLING BREATH

TOPI USE FROM ETHEREAL OILS TO THE TREATMENT OF WUNDHEILUNGSSTÖRUNGEN

Formulation and method of use

Provided is an orally administrable formulation comprising a flavour oil that includes menthol and/or limonene and an edible oil, in which both the flavour oil and the edible oil possess anti-inflammatory properties. Methods of using the aforementioned orally administrable formulation for decreasing and/or preventing an increase in body fat and/or body weight and the prevention and/or treatment of an inflammatory disease, disorder or condition, including obesity, asthma and inflammatory bowel disease, are also provided. Also provided are methods of producing the aforementioned orally administrable formulation.

Preparing stable liquid emulsion forms of plant extract

A method (10) for preparing stable liquid emulsion forms of plant extract is provided. A plant extract is mixed (11) with a diluent oil as an oil mixture. Heat is applied (13) to the oil mixture until the mixture reaches a threshold viscosity. An emulsifying agent is dispersed (14) in water as an emulsifying solution. The oil mixture and emulsifying solution are mixed (16) together. The mixed oil mixture and emulsifying solution are homogenized (17) as a liquid form of the plant extract.

Compositions and methods for joint health

The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of modulating joint inflammation, joint pain, joint stiffness, cartilage degradation, or improving mobility, range of motion, flexibility, joint physical function, or any combination thereof. Such a mixture of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both can optionally be used in combination with other joint management agents, such as non-steroidal anti-inflammatory agents/analgesics, COX/LOX inhibiting agents, glucosamine compounds, neuropathic pain relief agents, or the like.

Synergistic dietary supplement compositions for enhancing physical performance

GNA 114 WO 33 The present invention discloses novel synergistic dietary supplement compositions comprising at least two ingredients selected from the extracts and fractions derived from Sphaeranthus indicus, Coleus aromaticus, Cissus quadrangularis, Curcuma longa, Garcinia mangostana, Citrullus lanatus, Ocimum sanctum, Trachyspermum ammi and Cinnamomum tamala as natural energy enhancer for enhancing physical performance, muscle strength, muscle mass, mental alertness and energy levels in a mammal.

Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof

Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI

Hydration compositions for human or animal bodies

USE OF COMPOSITIONS CONTAINING PETASITES FOR TREATING DISEASES

Enteric coated multiparticulate controlled release peppermint oil composition and related methods

A multiparticulate composition is formed from a plurality of individual cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a hydrophilic phase containing a hydrogel. An enteric coating is over the individual cores. The multiparticulate composition can be used to treat gastrointestinal disorders.

A Formula of a Traditional Chinese Medicine Bacteriostatic Disinfectant and Preparation Method Thereof

The invention discloses a formula of a traditional Chinese medicine bacteriostatic disinfectant and a preparation method thereof, and relates to the technical field of traditional Chinese medicine. The formula raw materials of the traditional Chinese medicine compound bacteriostatic preparation comprise Radix Paeoniae Alba in Bozhou, Senecio scandens, golden-and-silver honeysuckle, Bo-Chrysanthemum and Mentha canadensis Linnaeus. The traditional Chinese medicine bacteriostatic preparation has a reasonable formula. It can effectively and quickly achieve bacteriostatic disinfection and sterilization effects. It also can be used for sterilization and disinfection for skin, mucous membrane, epidemic prevention and the like. The preparation method comprises the following steps. Decocting Radix Paeoniae Alba, Senecio scandens, golden-and-silver honeysuckle, Bo-Chrysanthemum and Mentha canadensis Linnaeus to obtain decoction liquid. Cooling the liquid to below 40°C, standing, filtering with membrane ...

Novel powder compositions

Anti-snoring composition

A pharmaceutical composition for stopping opium addiction and preparation thereof

ANTI-INFLAMMATORY ANALGESIC ADHESIVE PATCH

An anti-inflammatory analgesic adhesive patch which has an excellent anti- inflammatory analgesic effect and is reduced in unpleasant irritant feeling during wear. It is characterized by containing, as active ingredients, benzocaine and an ingredient having a counter-irritation effect, wherein the ingredient having a counter-irritation effect comprises one or more members selected from the group consisting of 1-menthol, dl-menthol, dl-camphor, d- camphor, methyl salicylate, glycol salicylate, peppermint oil, eucalyptus oil, capsaicin, capsicum extract, and nonylic acid vanillamide and the benzocaine is contained in an amount of 0.5 to 20 wt.%.

ANTIPHLOGISTIC

COMPOSITION AND METHOD FOR SMOKE DETOXIFICATION

A method is provided for effecting smoke detoxification in a human by using a composition that is made of effective amounts of supercritical extract and hydroalcoholic extract of turmeric.

MEDICAMENT FOR TREATMENT OF CLIMACTERIC SYNDROME OF WOMEN AND PREPARATION METHOD THEREOF

The present invention discloses a novel medicament for treatment of climacteric syndrome of women, which is prepared from Radix Ginseng, Radix Angelicae Sinensis, Radix Astragali seu Hedysari, Radix Ophiopogonis, Fructus Ligustri Lucidi, Rhizoma Atractylodis Alba, Radix Paeoniae Alba, Poria cocos, Cortex Phellodendri, Rhizoma Ligustici Wallichi, Radix Glycyrrhizae, Radix Bupleuri, Radix Rehmanniae Praeparata, Herba Epimedii, Herba Menthae, Rhizoma Curculiginis, Rhizoma Anemarrhenge, and Herba Ecliptae by processing raw TCM, decocting, drying, grinding, and adding water and honey in a certain proportion to yield aqueous-honey-bolus.

FOOD SUPPLEMENT, USES THEREOF, METHOD FOR FOOD SUPPLEMENTATION, AND ORAL SPRAY

The invention relates to a food supplement containing minerals and/or vitamins, a humectant and, for example, essential oils. The food supplement is formulated as an oral spray. In particular, the invention relates to a concentrated food supplement in the form of an oral spray, containing a combination of magnesium ions, panthenol (vitamin B5), caffeine, menthol aroma and/or peppermint aroma, and a humectant. The food supplement is particularly suited for use in sport and in stressful situations.

METHOD OF MARKING FILM-LIKE DOSAGE FORMS

Disclosed is a method for marking film-type dosage forms, comprising at least the positioning of a film-type dosage form between two layers of a sealable packaging material, the sectional heat-sealing of the two layers of the sealable packaging material so as to obtain an edge-sealed bag containing the film-type dosage form, and the blind-embossing of the film-type dosage form contained in the edge-sealed bag through at least one of the two layers of packaging material of the edge-sealed bag.

METHOD FOR THE PRODUCTION OF A PLANT-BASED MEDICAMENT

The present invention realtes to methods for the production of a plant-base d medicament which contains lberis amara, Menthae piperitae folium, Matricaria e flos, Carvi fructus, Melissae folium, Angelicae radix, Liquiritiae radix, Cardui mariae fructus and Chelidonii herba in the form of alcoholic extracts; to the medicaments produced according to these methods; and to the uses of such medicaments.

HONEY BEE MITE DISRUPTIVE COMPOUNDS AND METHODS OF APPLICATION

This disclosure describes compounds that affect the olfactory responses of the honey bee mite (Varroa destructor) and methods of use thereof. The compounds do not kill Varroa destructor, and are therefore unlikely to generate Varroa destructor resistance, compared to an acaricide. The compounds can work in conjunction with other mite control approaches, such as a bottom board excluder and sticky board control devices, and can enhance the performance of other forms of mite control while decreasing disadvantages associated therewith.

ENTERIC COATED MULTIPARTICULATE CONTROLLED RELEASE PEPPERMINT OIL COMPOSITION AND RELATED METHODS

A multiparticulate composition is formed from a plurality of individual cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a hydrophilic phase containing a hydrogel. An enteric coating is over the individual cores. The multiparticulate composition can be used to treat gastrointestinal disorders.

A MOUTH FRESHENER

The present disclosure envisages a mouth freshener composition comprising the extracts of Curcuma longa, Piper longum and Mentha arvensis. Further, the composition comprises at least one diluent, at least one sweetening agent, at least one binder, at least one preservative, at least one pharmaceutically acceptable fluid medium, at least one pharmaceutically acceptable flavoring agent, at least one pharmaceutically acceptable lubricant, optionally at least one pharmaceutically acceptable disintegrant, at least one pharmaceutically acceptable glidant, at least one pharmaceutically acceptable film forming agent, at least one pharmaceutically acceptable plasticizer. The present disclosure also envisages a process for preparing the mouth freshener composition. The mouth freshener composition alleviates halitosis, common cold, cough, sore throat and the symptoms of bronchitis. It also acts as a rejuvenator and Immunomodulator on prolonged use.

COMPOSITION COMPRISING INSULIN AND HERBAL OIL FOR TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION

The invention provides an a pharmaceutical composition for transdermal or transmucosal administration comprising insulin, insulin analogues or derivatives, an effective amount of herbal oil and one or more surfactant or polymeric ingredient optionally along with one or more pharmaceutically acceptable excipients for treating diabetic disorders.

AQUEOUS IONIC SOLUTION CONTAINING SEAWATER AND AT LEAST ONE COMPOUND THAT IS ORIGINALLY IMMISCIBLE WITH SEAWATER

L'invention concerne une solution ionique aqueuse, notamment destinée à un usage nasal, comprenant au moins: - une solution à base d'eau de mer présentant une osmolalité comprise entre 290 mOsm/kg et 400 mOsm/kg dans une proportion massique comprise entre 30% et 98% environ par rapport à la masse totale de la composition, - au moins un phospholipide cationique d'origine naturelle dans une proportion massique comprise entre 0,01% et 5% environ par rapport à la masse totale de la composition, - au moins un composé originellement non miscible à ladite solution à base d'eau de mer dans une proportion massique comprise entre 0,01% et 10% environ par rapport à la masse totale de la composition.

AQUEOUS IONIC SOLUTION CONTAINING SEAWATER AND AT LEAST ONE COMPOUND ORIGINALLY IMMISCIBLE WITH SEAWATER

The invention relates to an aqueous ionic solution, particularly for nasal use, including: at least one seawater solution having an osmolality of between 290 mOsm/kg and 400 mOsm/kg in a weight proportion of between about 30 and 98 wt % relative to the total weight of the composition; at least one cationic phospholipid of natural origin in a weight proportion of between about 0.01 and 5 wt % relative to the total weight of the composition; and at least one compound, which is originally immiscible with said seawater solution, in a weight proportion of between 0.01 and wt % relative to the total weight of the composition.

NATURAL VOLATILE PLANT OILS TO REPEL ARTHROPODS

A composition and method for the controlled release of natural plant oils (essential oils) from a wax matrix to repel insects, arachnids, and other arthropods.

PLANT EXTRACTS FOR IMPROVING COGNITIVE HEALTH AND FUNCTION

Extracts of plants of the Lamiaceae family are shown to improve cognitive health and function.

FREESKIN

The subject of the patent application is about a substance and its way of use that causes a complete process of curing from skin diseases such as: eczema and acne.The assumption that I have made is, that eczema and acne are a blood bacteria infection. The developed method of curing requires a certain amount of time. The method does not apply only to eczema and acne, but makes significant curing effects in peridontium diseases. The method can also be used as the prevention of all the above.

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HERPES

The invention relates to a pharmaceutical composition for the treatment of herpes simplex virus infections, comprising a quaternary ammonium compound as a first component and/or an antiviral agent as a second component and/or a plant extract as a third component, wherein the three components are mutually compatible, in a pharmaceutically acceptable base.

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HERPES

The invention relates to a pharmaceutical composition for the treatment of herpes simplex virus infections, comprising a quaternary ammonium compound as a first component and/or an antiviral agent as a second component and/or a plant extract as a third component, wherein the three components are mutually compatible, in a pharmaceutically acceptable base.

Verfahren zur Herstellung eines die Schwangerschaft und Geburt günstig beeinflussenden Mittels.

Verfahren zur Herstellung von nicht zur Verwendung als Arzneimittel bestimmten trockenen Verreibungen aus pflanzlichen oder tierischen Stoffen.

Agent for treating periodontitis

An agent for treating periodontitis contains a mixture of uniformly dried potassium alum and sodium bicarbonate, with the ratio of the weight of potassium alum to sodium bicarbonate being 2:1. Use of the said agent prevents bleeding of the gingiva and the agent can be used for treating gingivitis.

EXHAUSTING MEANS ON THE BASIS OF PLANTAGOSAMEN AND SENNAFRUECHTEN AND PROCEDURE FOR THE PRODUCTION OF THE SAME.

Herbal compsns. for promoting hair growth - contain nettle, pansy and chickweed

Compsns. contain a combination of herbs, including nettle (Urtica sp.), pansy (Viola tricolor) and chickweed (Stellaria media). The compsns. may also contain horsetail (Equisetum sp.), peppermint, soapwort (Saponaria sp.), burdock root, birch leaf, rosemary, walnut leaf, willow bark, hops, lavender, paprika, horseradish, garlic and/or onion. Toptical compsns. contain a cosmetic vehicle and opt. additives. Oral compsns. may also contain vitamins and minerals. ADVANTAGE - The combination has a synergistic effect.

Herbal medicaments prodn. - contg. essential antimicrobial oils and Echinacea tinctures, for treating infections, etc.

Herbal medicaments are prepd. by (a) dissolving 3-7 pts.wt. of antimicrobial essential oils in 90% EtOH; (b) adding a mixt. of 20-40 pts.wt. of a tincture of the leaves and roots of Echinacea angustifolia and E.pallida (1:1) and 20-40 pts. wt. of a tincture of the leaves and roots of E.purpurea; (c) diluting to 100 pts.wt. with 90% EtOH; (d) allowing the mixt. to stand; and (e) filtering off the ppte. to obtain the medicament as a clear soln. USE - Medicaments may be used to treat infections, colds, influenza, bronchitis, inflammations and infections of the oral cavity, nose and throat, infections of the urogenital tract, and immunodeficiency due to repeated infections.

Licking stone for alleviating discomfort in animals, containing active agents such as essential oils or herbal extracts

Licking stone (I) comprising a solid base material which can be absorbed by mammals, containing at least one additive (A) which alleviates discomfort, is new. ACTIVITY : Antitussive; antiinflammatory; antiparasitic; antipatasitic; anthelmintic; antimastitis; antibacterial; insecticidal; anxiolytic; hepatotropic; antiflatulent. MECHANISM OF ACTION : None given.

PLANT EXTRACT ABSTENTION PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR YOUR PRODUCTION.

Synergistic mixture of essential oils or essences

A composition (A) contains \- 2 natural essential oils and/or essences with a synergistic action in the biological, physiological and/or psychic areas of the organism. Also claimed is a composition (B) in the form of a concentrate, sprayable or dispersible diluate or aqueous and/or alcoholic liquid, oil, emulsion, cream, paste, gel or ointment, containing 0.5-99 (preferably 1-10) wt.% (A). Preferably (A) contains 3-8 essential oils selected from ginger, cedar, clove, templin, ylang-ylang, fennel, balm mint, benzoin, peppermint, geranium, bergamot, tagetes, cardamom, tea-tree, frankincense (olibanum), marjoram, lavender, eucalyptus, patchouli, sage, caraway, cajeput, thyme, peru balsam, lemon, sandalwood, rosemary, citronella, myrrh, cypress, orange blossom and/or vetiver oils. (A) optionally further contains one or more of: (i) an additional plant extract as active agent, preferably from Calendula, Urtica urens, Echinacea, Millefolium, Hamamelis, Aristolochia and/or Symphytum; (ii) \- 1 ...

Dried herbal mixture useful for medical and hygiene purposes and as a food supplement comprises balm, peppermint, rose leaf, rosemary, coriander, lemon peel and others

Dried herbal mixture comprises chopped balm leaf (9.6-10%), chopped peppermint leaf (9.6-10%), purified whole rose leaf (9.6-10%), chopped rosemary (9.6-10%), crushed coriander (9.6-10%), chopped lemon peel (9.6-10%), crushed juniper berry (9.6-10%), whole jasmine flower (7.2-7.55%), destemmed thyme (3.6-3.8%), ground hulled cardamom seed (2.4-2.5%), chopped mandarin peel (9.6-10%) and chopped Ceylon cinnamon (9.6-10%). ACTIVITY : Fertilizer. No biological data given. MECHANISM OF ACTION : None given.

Care solution, useful for disinfecting toothbrush, comprises a chlorhexidine digluconate, an aromatic plant extract, a plant extract with antiseptic properties, and a humectant

Care solution (I) comprises chlorhexidine digluconate, an aromatic plant extract, a plant extract with antiseptic properties, and a humectant. An independent claim is included for a single-dose comprising (I).

PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION WITH ANALGETIC AND ANTI-INFLAMMATORY EFFECT

КОМПОЗИЦІЯ ДЛЯ БОРОТЬБИ З НЕПРИЄМНИМ ЗАПАХОМ З РОТА

Композиція, яка містить суміш оливкової олії (Olea europea L.) та ефірної олії петрушки (Petroselinum sativum Hoffm., Petroselinum crispum Mill., Carum petroselinum Benth & Hooker) у масовому співвідношенні оливкової олії до ефірної олії петрушки у межах від 1 до 7. До складу згаданої композиції додатково можуть входити інші рослинні олії, м'ятна олія, ментол та хлорофіл. Ці композиції можуть існувати у декількох формах, у тому числі у вигляді цукерок, жувальної гумки, пасти для чищення зубів, рідин для полоскання роту та фармацевтичних композицій, зокрема м'яких желатинових капсул, для чого до їхнього складу включають відповідні добавки, носії та наповнювачі з метою забезпечення можливості одержання необхідної форми. Згадана композиція є придатною для лікування неприємного запаху з рота.

BIOLOGICALLY ACTIVE ADDITIVE FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES

METHOD FOR PREPARING AQUEOUS EXTRACTS OF PLANTS, EXTRACTS OBTAINED (VARIANTS), RAW MATERIAL FOR PREPARING EXTRACTS

PHARMACEUTICAL DISINFECTIVE PREPARATION BASED ON USNIC ACID SODIUM SALT AND MEDICAL PLANTS AND METHODS FOR PREPARATION THEREOF

VEGETABLE EXTRACT COMPOSITIONS AS ANTIMICROBIAL AND/OR ANTIBIOPLENOChNYI AGENT

MEANS FOR REFRESHING FOR ORAL CAVITY

Method of assisting with digestive upsets using a confection-based delivery of peppermint oil and ginger

A confection for assisting with the relief of common digestive complaints is provided. The confection includes a carbohydrate base and an active agent infused into the carbohydrate base. The active agent includes at least one of ginger extract or peppermint oil.

SKIN TEMPERATURE ELEVATING AGENT, AND COSMETIC COMPOSITION, FOOD AND SUNDRY ARTICLE CONTAINING THE SAME

An object of the present invention is to provide a skin temperature elevating agent that can further effectively raise a skin temperature. Another object is to provide a cosmetic composition, a food and a sundry article having a skin temperature elevating effect. A skin temperature elevating agent of the present invention is selected from one or more selected from a group consisting of: an extract of Japanese peppermint; an extract of clary sage; dihydro-β-ionol; and geraniol, and thus it can raise a skin temperature of a cheek. The skin temperature elevating agent according to the present invention is also selected from one or more selected from a group consisting of: an extract of Japanese peppermint; an extract of juniper berry; and 4-methoxystyrene, and thus it can raise a skin temperature of a hand fingertip. Hence, the skin temperature elevating agent according to the present invention can further effectively raise a skin temperature. A composition, a food, and a sundry article according to the present invention contain the skin temperature elevating agent, and thus have the skin temperature elevating effect. 1. A skin temperature elevating agent comprising one or more selected from a group consisting of: dihydro-β-ionol; 4-methoxystyrene; an extract of clary sage; an extract of Japanese peppermint; an extract of juniper berry; and geraniol.2. A skin temperature elevating agent comprising one or more selected from a group consisting of: dihydro-β-ionol; 4-methoxystyrene; an extract of clary sage; an extract of Japanese peppermint; an extract of juniper berry; and geraniol , at a total of equal to or greater than 0.001 mass % and equal to or smaller than 50 mass %.3. A cosmetic composition comprising the skin temperature elevating agent according to .4. A food comprising the skin temperature elevating agent according to .5. A sundry article comprising the skin temperature elevating agent according to .6. A cosmetic composition comprising the skin temperature ...

NASAL SPRAY

The invention relates to a medicinal product which is free from sympathomimetics, has an advantageous effect on the nasal mucosa in case of common colds, hay fever, dry nose and sympathomimetic dependencies, and is provided in the form of a nasal spray, a nasal douche or nasal drops. 1. A sympathomimetic-free medicinal product in the form of drops , spays , and/or rinses for use for preparing an agent for treating irritations of the nasal mucosa by a cold , by hay fever , a dry nose and/or sympathomimetic dependence , characterized by comprising menthol , mint oil and/or camphor as well as at least one humectant comprising water-soluble or water-dispersible natural or synthetic polymers that form gels or viscous solutions in aqueous systems , polyhydric alcohols , mono- , di- and/or polysaccharides.2. The sympathomimetic-free medicinal product according to claim 1 , characterized in that said polymers are selected from collagen derivatives claim 1 , polyalkylene glycols claim 1 , especially polyethylene glycols claim 1 , polyglycerols claim 1 , alginates claim 1 , carrageenan claim 1 , pectins claim 1 , gums claim 1 , cellulose derivatives claim 1 , polyvinyl alcohols claim 1 , polyvinyl pyrrolidones and derivatives thereof claim 1 , and/or dextran.3. The sympathomimetic-free medicinal product according to claim 1 , characterized by further containing panthenol.4. The sympathomimetic-free medicinal product according to claim 1 , characterized by containing said humectant in an amount of from 0.1 to 5% by weight.5. The sympathomimetic-free medicinal product according to claim 1 , characterized by further additionally containing common salt and/or sea salt.6. The sympathomimetic-free medicinal product according to claim 1 , characterized by additionally containing essential oils.7. The sympathomimetic-free medicinal product according to claim 1 , characterized by further containing pH control agents and/or tonicizing agents.8. The sympathomimetic-free medicinal ...

Composition for Reducing Side- and After-Effects of Cancer Treatment

A compound for consumption by cancer patients, or others currently suffering from side effects such as those commonly associated with chemotherapy, that supplies herbal tonics with certain properties believed to ameliorate many of the side effects discussed above, and which has taste masking properties that improve the patient's tolerance of the supplement and likelihood to consistently consume the supplement. The compound is a mixture generally containing three core components: whey protein, which has a number of significant health benefits for cancer patients; hepatoprotectant and/or nephroprotectant agents(s), which reduce damage to the kidneys and liver; and anti-emetic agent(s), which reduce nausea and vomiting. 1. A liquid composition comprising:whey protein;an anti-emetic; anda hepatoprotectant.2. The composition of wherein said anti-emetic provides the resultant taste profile of said composition.3. The composition of wherein said anti-emetic comprises ginger.4. The composition of wherein said hepaprotectant comprises milk thistle.5. The composition of further comprising a taste masking agent.6. The composition of wherein said taste masking agent comprises miraculin7. The composition of wherein the taste masking agent comprises a flavouring.8. A liquid composition consisting essentially of:whey protein;an anti-emetic; anda hepatoprotectant.9. The composition of wherein said anti-emetic provides the resultant taste profile of said composition.10. The composition of wherein said anti-emetic is selected from the group consisting of: ginger and peppermint.11. The composition of wherein said hepaprotectant is milk thistle.12. A method of treating the side effects of cancer treatment comprising administering a liquid composition comprising the following:whey protein;an anti-emetic; anda hepatoprotectant.13. The method of wherein said liquid composition is administered prior to a treatment being administered.14. The method of wherein said anti-emetic provides the ...

Method of Altering Perception of Time

Methods and compositions for modifying an individual's perception of an interval of time are disclosed. 1. A method of modifying a person's defective or impaired time processing , comprising administering to the person by inhalation an effective amount of a composition comprising a coffee odorant such that the person's estimate of the length of a time interval is shorter than the person's estimate of the same time interval made without inhalation of the composition.2. The method of claim 1 , wherein the composition consists essentially of the coffee odorant in a carrier claim 1 , and optional additives.3. The method of claim 1 , wherein the composition comprises a mixture of the coffee odorant with at least one of a peppermint odorant or a vanilla odorant as a secondary odorant that complements and does not mask the coffee odorant.4. The method of claim 3 , wherein the composition comprises a suprathreshold and non-irritant concentration of the coffee odorant and a less than suprathreshold concentration of the secondary odorant.5. A method of modifying a person's defective or impaired time processing claim 3 , comprising administering to the person by inhalation an effective amount of a composition comprising a baby powder odorant such that the person's estimate of the length of a time interval is longer than the person's estimate of the same time interval made without inhalation of the composition.6. The method of claim 6 , wherein the composition consists essentially of the baby powder odorant in a carrier claim 6 , and optional additives.7. The method of claim 1 , wherein the composition comprises a mixture of the baby powder odorant with a vanilla odorant as a secondary odorant that complements and does not mask the baby powder odorant.8. The method of claim 7 , wherein the composition comprises a suprathreshold and non-irritant concentration of the baby powder odorant and a less than suprathreshold concentration of the vanilla odorant.9. A method of treating a ...

Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof

A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.

Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof

A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.

Composition and method for minimizing bulling behavior of cattle

A method and composition for treating feedlot cattle in order to mask odor or pheromones given by cattle that trigger other cattle to mount them in a behavior pattern known as Buller Steer Syndrome, or to at least provide a scent which neutralizes that behavior.

Method For Producing Articles of Plant Origin Impregnated With a Liquid Plant Substance

The present invention relates to a method for producing articles impregnated with at least one plant substance from at least one plant, characterized in that it comprises the following steps: 1. A method for producing articles impregnated with at least one plant substance from at least one plant comprising ,{'b': 1', '1', '1, 'a) Extraction and/or pressing of at least one plant (V), or at least one part of said plant, thereby producing a liquid plant extract (E) and a solid fibrous residue (R), then'}{'b': 1', '1, 'b) Separation of said plant extract (E) from said fibrous residue (R), and'}{'b': '1', 'c) Destructuring of said fibrous residue (R),'}{'b': '1', 'd) Production of a fibrous web or of an article made from the fibrous residue (R) obtained in step c), and'}{'b': 1', '1', '1', '1', '2', '2', '2', '1, 'e) Impregnation of said fibrous residue (R) with (i) at least said plant extract (E), which is optionally concentrated, purified, flavored and/or fragranced, with (ii) at least one water-soluble or liposoluble plant substance isolated from said plant extract (E), with (iii) at least one composition comprising at least one optionally concentrated, purified, flavored and/or fragranced water-soluble or liposoluble substance of said plant extract (E), or with (iv) at least one plant extract (E) or at least one composition comprising at least one optionally concentrated, purified, flavored and/or fragranced water-soluble or liposoluble substance of said plant extract (E), resulting from an extraction or pressing of a plant (V) different from said plant (V).'}2. The method according to claim 1 , wherein steps c) claim 1 , d) and e) may occur in the following order:step c) precedes step d), which in turn precedes step e), orstep c) precedes step e), which precedes step d).3. The method according to claim 1 , wherein:the plant is chosen from among food plants, medicinal plants, aromatic plants and fragranced plants; or whereinthe plant is chosen from among plants ...

Pharmaceutical composition for treating melasma and preparation method thereof

A pharmaceutical composition for treating melasma is provided. The pharmaceutical composition is prepared from ginseng, salvia, mint, orange peel, peony, poria, licorice, peach seed, yam, and a fermentation conversion solution of fruits and vegetables. A preparation method of the pharmaceutical composition is also provided. 19-. (canceled)10. A method for preparing a pharmaceutical composition for treating melasma , comprising:mixing the following four substances for obtaining a mixture, wherein the mixture is the pharmaceutical composition for treating the melasma, wherein the four substances comprises:{'i': 'penthorum chienese', 'A) ethanol extract of ginseng and salvia; B) volatile oil of mint and orange peel; C) aqueous extract of the ginseng, the salvia, the mint, the orange peel, peony, poria, licorice, peach seed, yam and ; D) a fermentation conversion solution of fruits and vegetables;'}wherein a method for preparing the A) substance comprises: mixing the ginseng and the salvia, processing reflux extraction on the mixture with an aqueous solution of ethanol for obtaining extract and a first residue, collecting the extract, wherein the extract is the ethanol extract of the ginseng;wherein a method for preparing the B) substance comprises: immersing the mint and the orange peel in water, processing distillation extraction for obtaining distillate and a second residue, wherein the distillate is the volatile oil of the mint and the orange peel;{'i': penthorum chienese', 'penthorum chienese;, 'wherein a method for preparing the C) substance comprises: mixing the peony, the poria, the licorice, the peach seed, the yam, the , the first residue and the second residue, boiling, filtering and collecting filtrate, adding absolute ethanol and waiting for collecting supernatant, wherein the supernatant is the aqueous extract of the ginseng, the salvia, the mint, the orange peel, the peony, the poria, the licorice, the peach seed, the yam and the'}{'i': Lactobacillus ...

Antifungal serum

The subject invention is based upon the discovery that an antifungal agent can be delivered through the fingernail or the toenail of an infected human to treat onychomycosis by dissolving or dispersing the antifungal agent in a solvent system which is comprised of a combination of an alkyl lactate and Simmondsia chinesis seed oil. In accordance with this invention the antifungal agent is absorbed by and incorporated into the nail matrix by diffusing through the epithelium of the nail bed to reach the nail bed hyperkeratosis. The antifungal agent additionally penetrates into the ventral surface of the nail plate. The subject invention more specifically discloses an antifungal serum which is comprised of (1) an alkyl lactate, such as isoamyl lactate, (2) Simmondsia chinesis seed oil, and (3) an antifungal agent, such as tolnaftate or undecylenic acid.

ENTERIC COATED MULTIPARTICULATE CONTROLLED RELEASE PEPPERMINT OIL COMPOSITION AND RELATED METHODS

A multiparticulate composition is formed from a plurality of individual cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a hydrophilic phase containing a hydrogel. An enteric coating is over the individual cores. The multiparticulate composition can be used to treat gastrointestinal disorders. 1. A multiparticulate composition comprising a plurality of individual enteric coated cores , the cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a hydrophilic phase containing a hydrogel.2. The multiparticulate composition of claim 1 , further comprising a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings.3. The multiparticulate composition of claim 2 , wherein the continuous proteinaceous subcoating comprises a gelatin film adhered to the core.4. The multiparticulate composition of claim 2 , wherein the continuous proteinaceous subcoating comprises a dried proteinaceous gel.5. The multiparticulate composition of claim 2 , wherein the continuous proteinaceous subcoating is adapted to prevent the peppermint oil from mixing with the enteric coating.6. The multiparticulate composition of claim 2 , wherein the enteric coating has a glass transition temperature higher than a standard boiling point of the peppermint oil.7. The multiparticulate composition of claim 1 , wherein the enteric coated cores release no more than about 20% of the peppermint oil within about two hours of being placed in a 0.1 N HCl solution and claim 1 , subsequently claim 1 , no less than about 85% of the peppermint oil within about eight hours of being placed in a substantially neutral pH environment.8. The multiparticulate composition of claim 1 , wherein the enteric coated cores are spheroidal and not more than 3 mm in diameter.9. A multiparticulate composition comprising ...

Natural - Topical analgesic and anti-inflammatory composition F2

This invention replaces the practice of utilizing synthesized salicin compounds for use as anti-inflammatory components in topical pain relief compositions through the use of naturally occurring salicin in the form of (white willow bark) botanicals. This invention is a compound of naturally occurring botanicals identified in the Natural Pharmacopeia as individually exhibiting anti-inflammatory and/or analgesic properties. 1Helicrysum GymnocephalumSalix AlbaEucalyptus GlobulesLavandula AngustifoliaPelargonium GraveoleusMentha viridisMentha Avrensis,. As described in U.S. patient application Ser. No. 13/565 ,676 filed on Aug. 2 , 2012 , the combination of essential oil and extract when combined with essential oil , essential oil , essential oil , essential oil , Camphor , and incorporated into a cosmetic cream substrate , together constitute a unique and effective topical pain relief product.2Pimenta Racemosa,Cymbopogon flexuosus. It has been found that the effects of the compound described in above are enhanced by the addition (Dominican Bay Leaf) claim 1 , (Lemon Grass) to said compound. Test subjects reported that the enhanced compound provides a higher level of temporary pain relief claim 1 , that it is longer lasting. This is a continuation of U.S. patent application Ser. No. 13/565,676 dated 2013 Aug. 2.This invention is intended provide an alternative to synthetic topical pain relief preparations. This invention contains natural, botanical extracts and essential oils in lieu of synthetic analgesics and fragrance, replacing synthetic salicin based anti-inflammatory preparations.The invention is an emulsion of natural trans-dermal carriers and analgesic and anti-inflammatory components including (White Willow Bark) extract. The cream is compounded by combining the jojoba oil base with (White Willow Bark), the natural botanical extracts (Lavender), (Egyptian ), (Spearmint), (), (Rosemary), (Dominican Bay Leaf), (Lemon Grass), crystaline menthol and crystaline ...

Plant Extracts for Improving Cognitive Health and Function

Extracts of plants of the Lamiaceae family are shown to improve cognitive health and function. 1. A method to enhance , improve or sustain cognitive health and/or function in mammals , comprising oral administration of an efficacious amount of an extract of a plant of the Lamiaceae family.2. A method of claim 1 , wherein said mammals are selected from the list consisting of humans and companion animals.3. A method of claim 2 , wherein said efficacious amount of said extract is between 0.01 and 50 mg/kg/day.4. A method of claim 1 , wherein said extract comprises carnosic acid.5. A method of claim 4 , wherein cognitive health and/or cognitive function refers to procedural learning (through improvement of focus claim 4 , attention claim 4 , and alertness) and memory claim 4 , and wherein memory is selected from the group consisting of reference memory claim 4 , recognition memory claim 4 , short-term memory claim 4 , long-term memory and associative memory which have both declarative and procedural components.6. A method of claim 4 , wherein cognitive health and/or cognitive function refers to executive function7. A method of claim 2 , wherein said extract comprises rosmarinic acid.8. A method of claim 7 , wherein said efficacious amount of said extract is between 0.01 and 50 mg/kg/day.9. A method of claim 7 , wherein cognitive health and/or cognitive function for rosmarinic acid refers to declarative learning through improvement of focus claim 7 , attention claim 7 , and alertness.10. A method of claim 7 , wherein cognitive health and/or cognitive function for rosmarinic acid refers to declarative memory claim 7 , both short-term and long-term memory.11. A method of claim 7 , wherein cognitive health and/or cognitive function refers to executive function.12. A method of claim 1 , wherein said extract comprises carnosic acid and rosmarinic acid.13. A method of claim 12 , wherein to enhance claim 12 , improve and sustain cognitive health and/or function comprises ...

Medicinal tea

The medicinal tea includes a natural, herbal composition for treating female menstrual pains and post-delivery symptoms. The composition eliminates the side effects of common pain relief or sedative remedies. The composition includes Salvia officinalis, cumin, Artemisia herba - alba, Nigella sativa, Pimpinella anisum, coffee husk, Carum copticom, cinnamon, Achillea fragrantissima, and mint in specific amounts which together provide diuretic, sedative, menstrual and digestive benefits. This composition is easily digestible and provides immediate benefits without any harmful side effects.

Gargle Method to Reduce the Duration of Common Cold Symptoms

A method of reducing the presence, duration, severity, or symptoms of the common cold entails the administration of a nonalcoholic antiviral remedy to a subject in need of such treatment, preferably in the form of a gargle. 1. A method of treating a patient to reduce the duration or symptoms of the common cold , comprising administering by a gargling method an aliquot of an herbal containing at least one agent selected from the group consisting of antivirals , astringents , acids , antibiotics , minerals , salts , and antimicrobials to a patient in need of such treatment.2. A method of treating a patient to reduce the duration or symptoms of the common cold , comprising administering by the oral route of administration an effective amount of a substance selected from the group consisting of hydrogen peroxide , baking soda , garlic , cayenne pepper , zinc , vinegar , citric acid , malic acid , oxalic acid , benzoic acid , quinic acid , tannic acid , ginger extract , olive whole leaf , fennel , eucalyptus or ascorbic acid effective to treat said patient.3. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises hydrogen peroxide.4. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises vinegar.5. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises ascorbic acid.6. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises food grade acids (citric claim 2 , malic claim 2 , oxalic claim 2 , benoic claim 2 , quinic claim 2 , tannic claim 2 , the unique combination of ingredients found in fresh ginger claim 2 , and any other food grade acid).7. The method of claim 1 , wherein the nonalcoholic claim 1 , antiviral remedy comprises citrus fruit (orange claim 1 , mandarin claim 1 , lemon claim 1 , lime claim 1 , etc.).8. The method of claim 2 , wherein the nonalcoholic claim 2 , antiviral remedy comprises honey.9. The method of claim 2 , wherein the ...

OXIDIZED PROTEIN HYDROLASE ACTIVITY ENHANCING AGENT

The present invention provides a novel oxidized protein hydrolase activity enhancing agent. The oxidized protein hydrolase activity enhancing agent of the present invention contains at least one kind of plant extract obtained from a plant selected from the group consisting of water chestnut, stevia, rosemary, thyme, chrysanthemum, savory, mugwort, chestnut, spearmint, marjoram, peppermint, lemon balm, allspice, perilla, basil, and caraway. 1. (canceled)2. (canceled)3. A method for enhancing activity of oxidized protein hydrolase in a sample , comprising:adding oxidized protein hydrolase activity enhancing agent to the sample.4. A method for accelerating protein degradation in a sample comprising:{'claim-ref': {'@idref': 'CLM-00003', 'claim 3'}, 'adding an oxidized protein hydrolase activity enhancing agent according to to the sample.'}5. (canceled)6. A method for treating senescence of tissues caused by accumulation of AGEs in a subject , the method comprising:{'claim-ref': {'@idref': 'CLM-00003', 'claim 3'}, 'administering an oxidized protein hydrolase activity enhancing agent according to .'}7. A method for treating hypofunction of tissues caused by accumulation of AGEs in a subject , the method comprising:{'claim-ref': {'@idref': 'CLM-00003', 'claim 3'}, 'administering an oxidized protein hydrolase activity enhancing agent according to .'}8. The method according to claim 3 , wherein the oxidized protein hydrolase activity enhancing agent comprises two or more kinds of plant extracts selected from the group consisting of those obtained from water chestnut claim 3 , stevia claim 3 , rosemary claim 3 , thyme claim 3 , chrysanthemum claim 3 , savory claim 3 , mugwort claim 3 , chestnut claim 3 , spearmint claim 3 , marjoram claim 3 , peppermint claim 3 , lemon balm claim 3 , allspice claim 3 , perilla claim 3 , basil claim 3 , and caraway.9. The method according to claim 4 , wherein the oxidized protein hydrolase activity enhancing agent comprises two or more kinds ...

HOMEOPATHIC METHOD FOR TREATING COLIC, GAS AND UPSET STOMACH IN INFANTS

The present invention generally relates to homeopathic compositions, and, more particularly, (i) homeopathic compositions comprising a homeopathically potentised form of (Passionflower), and a homeopathically potentised form of (Nutmeg); or (ii) a homeopathically potentised ; and a homeopathically potentised ; or (iii) a homeopathically potentised ; and a homeopathically potentised ; and methods of treatment using these homeopathic compositions. 142-. (canceled)43Carbo Vegetabilis. A homeopathic composition comprising homeopathically potentised formulated in a liquid suspension.44Carbo Vegetabilis. The homeopathic composition of claim 43 , wherein the homeopathically potentised form of the is at a potency of 1× or 2×.45Carbo Vegetabilis. The homeopathic composition of claim 43 , wherein the is triturated with a sugar alcohol selected from the group consisting of Xylitol claim 43 , Mannitol and Sorbitol or a combination thereof.46Carbo Vegetabilis. The homeopathic composition of claim 43 , wherein the is produced from activated carbon having an iodine number of at least 900 mg/g.47Carbo Vegetabilis. The homeopathic composition of claim 43 , wherein the comprises activated carbon particles having a mean particle size of about 15 microns to about 60 microns with at least 90% of mass contained in particles (% Подробнее

METHOD FOR OBTAINING AN EXTRACT ENRICHED IN ROSMARINIC ACID FROM FRESH PLANT MATERIAL

Methods for obtaining an extract enriched in rosmarinic acid from fresh plant material selected from the fresh aerial parts, flowering tops, flowers and/or leaves of plants from the family Lamiaceae, Araliaceae, Boraginaceae, Apiaceae, Poaceae and Malvaceae. The methods include steam bleaching the plant material followed by continuous expression with at least one compression screw, under pressure of between 4 and 10 bar from which the sap (liquid co-product) is recovered. Then, the sap is filtered to produce a clarified sap and is subsequently atomized to obtain a granulated or finely powdered extract containing at least 5% of rosmarinic acid in weight relative to the total weight of the extract. Compositions having such an extract as an active agent are disclosed. The compositions are used in the food, cosmetic, nutraceutical and pharmaceutical fields. 1. A method for obtaining an extract enriched in rosmarinic acid from fresh plant material selected from the fresh aerial parts , flowering tops , flowers and/or leaves of plants from the family Lamiaceae , the method comprising:1) steam bleaching said plant material for less than 2 hours at atmospheric pressure at a temperature of 100° C.;2) continuous expressing with at least one compression screw, under pressure between 4 and 10 bar, of the plant material bleached in 1) with recovery of the sap;3) filtering the recovered sap in 2) to produce a clarified sap; and4) atomizing the clarified sap to obtain a granulated or finely powdered extract containing at least 5% of rosmarinic acid in weight relative to the total weight of the extract.2. (canceled)3. (canceled)4SalviaRosmarinus officinalisOriganum vulgareMentha piperitaSatureja hortensisMelissa officinalis. The method according to claim 1 , wherein the plant material is selected from sage (ssp) claim 1 , rosemary () claim 1 , oregano () claim 1 , mint () claim 1 , summer savory (L.) claim 1 , and lemon balm (L.).5. (canceled)6. The method according to claim 1 , ...

COMPOSITION AND A METHOD FOR WOUND HEALING

A herbal composition for wound healing is disclosed. The herbal composition comprises an extract of honeysuckle and an extract of mint in a weight ration of 1:2 to 2:1. The herbal composition further comprises a medical acceptable excipient. 1. A herbal composition comprising an extract of honeysuckle and an extract of mint in a weight ratio of 1:2 to 2:1.2. The herbal composition as claimed in claim 1 , wherein the weight ratio of the extract of honeysuckle and the extract of mint is 1:1.3. The herbal composition as claimed in claim 1 , wherein the extract of honeysuckle is an ethanolic extract via 50% ethanol.4. The herbal composition as claimed in claim 1 , wherein the extract of mint is a water extract of mint.5. The herbal composition as claimed in claim 1 , wherein the herbal composition further comprises a medical acceptable excipient.6. The herbal composition as claimed in claim 5 , wherein the herbal composition comprises 5 wt % of the extract of honeysuckle and 5 wt % of the extract of mint.7. The herbal composition as claimed in claim 5 , wherein the medical acceptable excipient is a polyethylene glycol.8. The herbal composition as claimed in claim 7 , wherein the polyethylene glycol has a molecular weight between 200-10000 kDa.9. A method for wound healing claim 5 , said method comprising administrating an effective amount of the herbal composition as claimed in to a target in need thereof.10. A method for wound healing as claimed in claim 9 , wherein the effective amount of the herbal composition is 0.75 kg/per mof wound area. 1. Field of the InventionThe present invention relates to a composition and, more particularly, to a herbal composition for wound healing. The present invention further relates to a method for wound healing by administrating the herbal composition to a target in need.2. Description of the Related ArtWounds comprising crush wounds, cuts, incisions, squeeze wounds, stab wounds or wounds due to surgery, plastic surgery or chronic ...

Composition Comprising Plants Extracts that Synergistically Treat or Inhibit Pathological Conditions and Method of Making

A composition including plant extracts that synergistically treat or inhibit pathological conditions and a method for developing the composition is provided. The composition includes bioactive chemical agents extracted from the plant species including, but not limited to, acetonide, catalpol, hispidulin, loliolide, neptin, rhamnose, and scutellarin, and bioactive chemical agents extracted from the plant species including, but not limited to, cadinol, diosmetin, eugenol, furfural, hesperidin, luteolin, and piperitone. The method includes the steps of washing and plant material, freezing the plant material, cutting the frozen plant material into pieces, heating the plant material in purified water to form a resultant solution containing and plant extracts, cooling the resultant solution, and filtering the and plant material out of the resultant solution to produce the composition. 1Plantago majorMentha spicata) A composition for inhibiting or treating pathological conditions , the composition comprising an effective amount of a plurality of plant extracts from a plant species and an effective amount of plurality of plant extracts from a plant species.2) A composition for inhibiting or treating pathological conditions , the composition comprising an effective amount of a plurality of plant extracts including acetonide , adenine , allantoin , apigenin , apigenin-7-glucoside , asperuloside , aucubin , baicalein , baicalin , benzoic acid , caffeic acid , catalpol , chlorogenic acid , cinnamic acid , D-glucose , D-xylose , ferulic acid , fumaric acid , geniposidic acid , gentisic acid , glucoraphanin , hispidulin , hydroxycinnamic acid , loliolide , luteolin , luteolin-7-O-beta-D-glucoside , neochlorogenic acid , nepetin , oleanolic acid , P-coumaric acid , P-hydroxybenzoic acid , phenolcarbonic acid , rhamnose , saccharose , salicylic acid , scutellarin , sitosterol , succinic acid , sulforaphane , syringic acid , syringin , tyrosol , ursolic acid , vanillic acid , acetic ...

FORMULATION FOR ALLEVIATION OF KIDNEY STONE AND GALLSTONE SYMPTOMS AND METHOD OF TREATMENT

A nutraceutical formula and food-based medicinal composition is provided comprising homeopathic ingredients in combination with traditional herbal and nutraceutical ingredients for relieving the symptoms associated with presence or formation of kidney stones and gallstones. The formulation includes ingredients balanced in a synergistic manner to elicit complementary effects which both reduce the symptoms of kidney stones and gallstones and provide the potential to eliminate their occurrence in the body and prevent future recurrence. Methods of making and using core medicinal formulations and food-based compositions are also described.

ANALGESIC COMPOSITIONS AND METHODS OF USE

The invention relates to the fields of pharmacology and medicine, and provides anesthetic compositions and methods for the treatment of pain using compositions comprising Tea tree oil and one or more additional agent. The invention relates to analgesic compositions for the treatment of pain associated with a variety of disorders or conditions, particularly oral or dental disorders or conditions such as alveolar osteitis or dental caries. 1. An anesthetic composition comprising a combination of Tea tree oil and one or more additional agent , comprising 0.1 ml to 1.0 ml of Tea tree oil.2. The anesthetic composition of claim 1 , wherein the ratio of Tea tree oil to the one or more additional agent is a 6:1 part by weight relationship.3. The composition of claim 1 , wherein the additional agent is selected from the group consisting of Ginger root oil claim 1 , Peppermint leaf oil claim 1 , Chamomile flower oil claim 1 , Olive leaf extract oil claim 1 , Grape seed oil claim 1 , Clove oil claim 1 , a flavoring syrup claim 1 , and an additional anesthetic agent.4. The composition of claim 3 , wherein the flavoring syrup is Cherry syrup.5. The composition of claim 3 , wherein the additional anesthetic agent is a topical anesthetic agent.6. The composition of claim 5 , wherein the topical anesthetic agent is selected from the group consisting of benzocaine claim 5 , lidocaine claim 5 , and tetracaine.7. The composition of claim 5 , wherein the topical anesthetic is benzocaine.8. The composition of claim 2 , comprising the Tea tree oil claim 2 , Ginger root oil claim 2 , Peppermint leaf oil claim 2 , Chamomile flower oil claim 2 , Olive leaf extract oil claim 2 , Grape seed oil claim 2 , Clove oil claim 2 , the flavoring syrup claim 2 , and an additional anesthetic agent in a ratio of about a 6:1:1:1:1:1:1:1:1 part by weight relationship.9. The composition of claim 1 , wherein the composition further comprises zinc oxide and/or water soluble poly(ethyleneglycol) (PEG).10. The ...

Formulation for treatment of irritable bowel disease

The present invention relates to an effective formulation for the treatment or the prevention of irritable bowel syndrome, a method for treating irritable bowel syndrome, and processes for preparing such formulations.

Health Supplement using Guarana Extract

The current invention is a supplement made from a combination of herbs, vitamins, amino acids which in the preferred embodiment is a 100% vegetarian liquid capsules that are ingested allow for rapid absorption. The components of the supplement can be mint or menthol such as peppermint or spearmint, Methyl B12 or B12, Niacin, Guarana, Dimethylaminoethanol, Acetyl-L-carnitine or ALCAR, Ocimum tenuiflorum, one or more teas such as green tea, white tea or black tea, Ginkgo, Rhodiola rosea, phosphatidylserine, Tyrosine, L-Alpha Glycerylphosphorylcholine, Citicoline (INN), Huperzine A, and Vinpocetine.

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING BURNOUT SYNDROME

The present specification relates to a composition for preventing, alleviating or treating burnout syndrome, containing a natural extract as an active ingredient. According to one aspect of the present invention, the composition contains a fruit extract, and thus is useful for preventing, treating and alleviating burnout syndrome. In addition, according to one aspect of the present invention, the composition further contains fruit and one or more selected from the group consisting of red , and , so as to maximize the synergistic effect among two or more ingredients, thereby exhibiting excellent effects on the prevention, treatment and alleviation of burnout syndrome. Therefore, there is an advantage of making individuals and society mentally and physically healthy since burnout syndrome can be prevented, treated and alleviated, by using the composition of the present invention. 1ginseng. A method for preventing or improving burnout syndrome , comprising administering an effective amount of a berry extract to a subject in need thereof.2. (canceled)3ginseng. The method according to claim 1 , wherein the composition comprises 0.01-70 wt % of the berry extract based on the total weight of the composition.4ginseng. The method according to claim 1 , wherein the berry extract comprises 8.0-30.0 wt % of ginsenoside Re based on the total weight of the composition.5ginseng. The method according to claim 4 , wherein the berry extract comprises each 0.1-10 wt % of a ginsenoside Rb1 claim 4 , a ginsenoside Rb2 claim 4 , a ginsenoside Rb3 claim 4 , a ginsenoside Rc claim 4 , a ginsenoside Rd claim 4 , a ginsenoside Rg1 or a ginsenoside Rg2 based on the total weight of the composition.6ginseng. The method according to claim 1 , wherein the berry extract comprises 23-80 wt % of total ginsenosides.7ginseng. The method according to claim 1 , wherein a ratio of PD ginsenosides to PT ginsenosides in the berry extract is 0.63-1.5.8ginsengangelica. The method according to claim 1 , ...

COMPOSITIONS FOR PERIODONTAL ADJUNTIVE THERAPY

The scaling, root planning, and curettage procedure, even without additional treatment, benefits the patient by providing a reduction in pocket depth. The present disclosure provides high pH periodontal adjuvant compositions that, in conjunction with scaling and root planning, can reduce or eliminate a population of bacteria from a site of periodontal treatment. The compositions are applied as a paste and removed by lavage, thereby reducing or removing an active periodontal infection and allowing the periodontium to return to a state of health. 1. A periodontal adjunct composition consisting of potassium hydroxide , a metal salt , a phenolic compound , an Hreceptor antagonist , and an essential oil , wherein the potassium hydroxide is between about 54% and about 95% by weight; the metal salt is between about 0.5% and about 5% by weight; the phenolic compound is between about 0.5% and about 5% by weight; the essential oil is between about 0.5% and about 5% by weight; and the Hreceptor antagonist is between about 0.1% and about 1% by weight , wherein % by weight is % by weight of the final composition weight.2. The periodontal adjunct composition of claim 1 , wherein the composition is admixed with an excipient.3. (canceled)4. The periodontal adjunct composition of claim 1 , wherein the Hreceptor antagonist is selected from the group consisting of: cimetidine claim 1 , nizatidine claim 1 , famotidine claim 1 , and ranitidine.5. (canceled)6. The periodontal adjunct composition of claim 1 , wherein the phenolic compound is selected from the group consisting of thymol claim 1 , carvacrol claim 1 , cresol claim 1 , estradiol claim 1 , eugenol claim 1 , gallic acid claim 1 , guaiacol claim 1 , methyl salicylate claim 1 , raspberry ketone claim 1 , salicylic acid claim 1 , sesamol claim 1 , tumeric claim 1 , phenol claim 1 , bisphenol A claim 1 , BHT claim 1 , 4-nonylphenol claim 1 , orthophenyl phenol claim 1 , phenolphthalein claim 1 , and xylenol.7. The periodontal ...

Edible Product Comprising Reconstituted Plant Material

The present invention relates to an edible product, which comprises a fibrous plant product and a plant extract applied thereto. Further, the invention relates to a corresponding method for producing said edible product and its use in at least one of food, food supplement, medicinal, cosmetic, well-being, nutraceutical or phytotherapeutical applications. The plants used may be all plants comprising one or more substances of interest for an edible product. 1. An edible product , the product comprising a layer of a fibrous plant product and a plant extract applied to the layer of the fibrous plant product.2. The product of claim 1 , wherein the fibrous plant product comprises substances from one or more specific parts of one or more plants.3. The product of claim 1 , wherein the plant extract comprises substances from one or more specific parts of one or more plants.4. The product of claim 1 , wherein the fibrous plant product comprises substances from one or more specific parts of one or more plants or the plant extract comprises substances from one or more specific parts of one or more plants or a combination thereof claim 1 , and wherein the plants are selected from one or more of the group consisting of herbs claim 1 , medicinal plants claim 1 , tea claim 1 , vegetables claim 1 , or spices.5AbelmoschusAbiesAbroma augusta, AcaciaAcalypha indica, Acanthus mollis, AcerAchilleaAchyranthes bidentata, Acmella oleracea, Acorus calamus, ActaeaActinidiaAdansonia digitata, AdiantumAdoxa moschatellina, Aegopodium podagraria, AesculusAframomumAgathosmaAgaveAgrimoniaAjugaAlaria esculenta, AlbiziaAlcea rosea, Alchemilla vulgaris, Aletris farinosa, AlismaAlliaria petiolata, AlliumAlnusAloeAloysia citriodora, AlpiniaAlthaea officinalis, AmaranthusAmmi visnaga, Amomum villosum, Amorphophallus konjac, Amyris balsamifera, Anacardium occidentale, Ananas comosus, Andrographis paniculata, Anemarrhena asphodeloides, AngelicaAngostura trifoliata, Aniba rosaeodora, AnnonaAnogeissus ...

Extraction Technology of Xiao-Yao-Drink

An extraction technology of a Xiao-yao-drink includes a medicine preparing step of preparing herbal medicines, a pulverizing step of pulverizing the herbal medicines to produce medicinal solid particles, a liquid extracting step of adding the medicinal solid particles into an extraction liquid to dissolve the medicinal solid particles in the extraction liquid, an ultrasonic extraction step of impacting the medicinal solid particles in the extraction liquid by concentrated ultrasonic waves to crush the medicinal solid particles into medicinal molecules, and a centrifugal filtering step of filtering the medicinal molecules from the extraction liquid by a strainer cloth to produce a medicinal extract which constructs a Xiao-yao-drink product. Thus, the extraction technology uses an ultrasonic extraction procedure to crush the medicinal solid particles into medicinal molecules by concentrated ultrasonic waves to efficiently increase the active component of the herbal medicine. 1. An extraction technology of a Xiao-yao-drink , comprising:a medicine preparing step of preparing a plurality of herbal medicines;a pulverizing step of pulverizing the herbal medicines to produce medicinal solid particles;a liquid extracting step of adding the medicinal solid particles into an extraction liquid to dissolve the medicinal solid particles in the extraction liquid;an ultrasonic extraction step of impacting the medicinal solid particles in the extraction liquid by concentrated ultrasonic waves to crush the medicinal solid particles in the extraction liquid into medicinal molecules; anda centrifugal filtering step of filtering the medicinal molecules from the extraction liquid by a strainer cloth to produce a medicinal extract which constructs a Xiao-yao-drink product;{'i': Mentha arvensis, Glycyrrhiza uralensis, Zingiber officinale, Angelica sinensis, Vatica mangachagpoi', 'Wolfiporia cocos, Atractylodes macrocephala', 'Paeonia lactiflora., 'wherein in the medicine preparing step, ...

Medicament for use in treating diabetes

A medicament for treating diabetes and complications thereof, the medicament being a glycoprotein, or a mixture of a polysaccharide and a protein, or a polypeptide, or a protein.

Antioxidant infused gum for improving oral health

Disclosed herein are compositions and methods for treating, reducing or preventing oxidative stress in a subject. The compositions can be chewable confectionaries comprising a chewable base, one or more unprocessed phytochemical ingredients, and a sweetener comprising allulose. The unprocessed phytochemical ingredients can include ground plant materials selected from cinnamon, nutmeg, allspice, or combinations thereof. The chewable confectionary can exhibit a polyphenolic content of at least 100 μg gallic acid equivalents (GAE) or greater, per gram of the chewable confectionary and an antioxidant capacity of at least 3,200 μM Trolox equivalents per gram of the chewable confectionary, as determined by the oxygen radical absorbance (ORAC) assay. Kits, methods of making and using the chewable confectionary are also disclosed.

Enteric Coated Multiparticulate Composition With Proteinaceous Subcoat

A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings. The continuous proteinaceous subcoating layer prevents volatile terpene-based active ingredients from leaving the core, even when the core is heated during processing or stored for long periods above room temperature. The multiparticulate composition may be used to treat gastrointestinal disorders. 1. A multiparticulate dosage form comprising a plurality of individual enteric coated particulates having (a) a solid core containing an effective amount of at least one volatile terpene-based active ingredient , (b) a continuous proteinaceous subcoating over the core , and (c) an enteric coating over the subcoating , the subcoating being effective to prevent the volatile terpene-based active ingredient(s) from substantially penetrating the subcoating and contacting the enteric coating when stored at a temperature of 40 degrees C. and 75% relative humidity from between 1 day to 30 days.2. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes L-menthol from an at least 80% pure L-menthol source.3. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes peppermint oil.4. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes L-menthol from an at least 80% pure L-menthol source dissolved in peppermint oil.5. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes both L-menthol and caraway oil.6. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes ...

WEIGHT LOSS FORMULATION

A weight loss product comprises a mixture of , and (in the weight proportion 12:10:5:4), to which additional ingredients have been added to increase weight loss efficacy. The additional ingredients may include, but are not limited to, Gamma-oryzanol, Caffeine, Cirsimarin, Fucoxanthin, Guggulsterones, Evodiamine, Forskolin, Sclareolide, Chromium, Hydroxycitric acid, Pinolenic acid, Conjugated linoleic acid, Potato protein, Raspberry ketone, Capsaicin, Synephrine, Dehydroepiandrosterone, Phenylethylamine, Orlistat, Glucomannan, or Vitamin C, or sources thereof, as well as herbal ingredients such as , Damiana, Green tea, Green coffee bean, Cinnamon, White kidney bean, , Nopal Cactus, Hoodia, Yohimbine, , Cayenne, Pomegranate, Blueberry, Billberry, or extracts of such herbal ingredients, and plant sources of antioxidants. A preferred additional ingredient is caffeine provided by caffeine anhydrous, , and kola nut. Other additional ingredients may be used as well in accordance with specific disclosed formulations. 1. A weight loss composition comprising:{'i': Alchemilla vulgaris, Olea europaea, Cuminum cyminum', 'Mentha longiflora, 'a mixture of , and ; and'} (i) Gamma-oryzanol, Caffeine, Cirsimarin, Fucoxanthin, Guggulsterones, Evodiamine, Forskolin, Sclareolide, Chromium, Hydroxycitric acid, Pinolenic acid, Conjugated linoleic acid, Potato protein, Raspberry ketone, Capsaicin, Synephrine, Dehydroepiandrosterone, Phenylethylamine, Orlistat, Glucomannan, or Vitamin C, or sources thereof, or', {'i': Guarana, Yerba Mate', 'Garcinia Cambogia', 'Malpighia glabra, Eurycoma Longifolia, Caralluma Fimbriata, Citrus aurantium, Gymnema Sylvestre, Lyceum barbarurn, Aloe Vera', 'Punica granatum, '(ii) herbal ingredients selected from the group comprising , Damiana, Green tea, Green coffee bean, Cinnamon, White kidney bean, , Nopal Cactus, Hoodia, Yohimbine, , Cayenne, , Blueberry, Billberry, or extracts thereof.'}], 'at least one additional ingredient selected from one of the ...

Enteric Coated Multiparticulate Composition With Proteinaceous Subcoat

A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings. The continuous proteinaceous subcoating layer prevents volatile terpene-based active ingredients from leaving the core, even when the core is heated during processing or stored for long periods above room temperature. The multiparticulate composition may be used to treat gastrointestinal disorders. 1. A method of treating a gastrointestinal disorder in a human subject , the method comprising administering to the subject a multiparticulate dosage form composition effective to treat a gastrointestinal disorder in the subject , the composition comprising a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings.2. The method of claim 1 , wherein administering is performed enterally.3. The method of claim 2 , wherein administering is performed orally.4. The method of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol from an at least 80% pure L-menthol source dissolved in a terpene-containing essential oil.5. The method of claim 1 , wherein the one or more terpene-based active ingredients include both L-menthol and caraway oil.6. The method of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol from an at least 80% pure L-menthol source dissolved in peppermint oil.7. The method of claim 1 , wherein the one or more terpene-based active ingredients include both peppermint oil and caraway oil.8. The method of claim 1 , wherein the one or more terpene-based active ingredients include both L-menthol and ...

EXTERNAL-USE MEDICAMENT FOR CLEANING AND CARE OF THE OVARIES, VAGINA AND VULVA

An external-use agent for cleaning and caring ovaries, vagina and vulva, which is produced by medical raw materials consisting of propolis extract, zedoary oil, and mint leaf filtrate is provided. On the basis of different properties of each natural Chinese herbal material, using supercritical COtechnology, separation and extraction, and low-temperature centrifugation are carried out respectively, and they are processed for preparation in a proportion, and then the membrane separation is performed, so that a spraying agent or a caring product is manufactured. It may be used alone in a female reproductive system for preventing the repeated infection and for achieving vulval bacteriostatic or antibacterial purposes and cleaning and deodorizing the vagina, eliminating vulval pruritus, and refreshing and moisturizing vulva and vagina etc., with good cleaning and caring functions and achieving a significant effect. 1. An external-use agent for cleaning and caring ovaries , vagina and vulva , characterized in that the external-use agent , is manufactured using raw materials , as active ingredients , based on parts by weight as follows:Propolis extract 1˜10,Zedoary oil 5˜10, andMint leaf filtrate 50˜100,wherein a method for preparing the external-use agent comprises following process steps of:{'sub': 2', '2, 'preparing the propolis extract, including: loading raw propolis into a COextraction tank and circularly adding COliquid to perform extraction with an extraction temperature of 15˜30° C., an extraction pressure of 8˜10 MPa, and extraction time of 1 to 2 hours, to obtain the propolis extract, a propolis content of which is 1% to 3% of amount of the raw propolis;'}{'sub': 2', '2, 'preparing the zedoary oil, including: directly loading zedoary seeds into a COextraction tank and circularly adding COliquid to perform extraction with an extraction temperature of 20˜30° C., an extraction pressure of 2˜7 MPa, and extraction time of 1˜2 hours, to obtain zedoary oil extract ...

ANTI-MICROBIAL AMALGAMATE OF NON-TOXIC NATIVE COMPOSITION

An anti-microbial formulation of native ingredients for human and non-human vertebrate animal feeds, feed supplements/additives, or for direct doses to replace in whole or supplement traditional anti-microbial with side-effects such as allergies, microbial-resistance, and drug-interactions with non-toxic, side-effect free native anti-microbial for all vertebrates. The invention comprises of non-toxic, side-effect free native substances amalgamations having anti-microbial properties for food additives, food supplements, or direct doses. Furthermore, these native formulas can be use with or without other prescription or nonprescription anti-microbial medications. We describe the method of manufacture and also the process of use for this amalgamates. 1. An anti-microbial composition comprising coconut/MCT oil , Elantria DHA 400 algae , cranberry seed , black cumin , oregano , carob , and Agaricus mushroom; wherein the composition is side-effect-free in any vertebrate; and wherein the composition is non-toxic to any vertebrates.2. The composition of claim 1 , further comprises at least one or more selected from chia claim 1 , krill claim 1 , micro-algae claim 1 , cinnamon claim 1 , lemon claim 1 , coriander claim 1 , ginger claim 1 , peppermint claim 1 , fenugreek claim 1 , moringa claim 1 , insect protein claim 1 , cardamom claim 1 , or any combination thereof.3. The composition of any of claim 1 , wherein krill comprises from 5% to 40% by weight/volume claim 1 , wherein micro-algae comprises from 5% to 40% weight/volume claim 1 , wherein cranberry seed comprises from 0.1% to 10% by weight/volume claim 1 , wherein chia comprises from 5% to 30% by weight/volume claim 1 , wherein black cumin comprises from 0.05% to 5% by weight/volume claim 1 , wherein carob comprises from 0.1% to 5% by weight/volume claim 1 , and wherein cardamom comprises from 0.01% to 5% by weight/volume or any combination thereof.4. The composition of claim 1 , wherein oregano oil 11-24% claim 1 , ...

Nanoparticle-stabilized microcapsules, dispersions comprising nanoparticle-stabilized microcapsules, and method for the treatment of bacterial biofilms

A stabilized microcapsule includes a liquid hydrophobic core including an essential oil and an aromatic monoaldehyde, and a shell encapsulating the core, the shell including a plurality of amino-functionalized inorganic nanoparticles. Also disclosed is a dispersion including a plurality of the stabilized microcapsules. The microcapsules and dispersions can be particularly useful for treating a bacterial biofilm.

Caudal Salve

A caudal salve is a topical treatment for irritated skin around a user's posterior. The caudal salve includes a plurality of ingredients that each has their own unique beneficial properties. The plurality of ingredients includes a quantity of bees wax, a quantity of shea butter, a quantity of coconut oil, a quantity of yarrow-plant oil, a quantity of calendula-flower oil, a quantity of menthol, and a quantity of peppermint oil. The bees wax, the shea butter, and the coconut oil are typically used as the base materials for the caudal salve. The yarrow-plant oil, the calendula-flower oil, the menthol, and the peppermint oil are typically used as the supplemental yet active materials for the caudal salve. 1. A caudal salve comprises:a quantity of bees wax;a quantity of shea butter;a quantity of coconut oil;a quantity of yarrow-plant oil;a quantity of calendula-flower oil;a quantity of menthol; anda quantity of peppermint oil.2. The caudal salve as claimed in comprises:said quantity of bees wax being about 20% wt of said caudal salve;said quantity of shea butter being about 25% wt of said caudal salve;said quantity of coconut oil being about 25% wt of said caudal salve;said quantity of yarrow-plant oil being about 5% wt of said caudal salve;said quantity of calendula-flower oil being about 5% wt of said caudal salve;said quantity of menthol being about 15% wt of said caudal salve; andsaid quantity of peppermint oil being about 5% wt of said caudal salve.3. The caudal salve as claimed in comprises:said quantity of shea butter comprises a plurality of topically beneficial constituents; andsaid plurality of topically beneficial constituents includes a high vitamin-A content, a high vitamin-E content, a vitamin-F content, and a cinnamic-acid content.4. The caudal salve as claimed in comprises:said quantity of coconut oil comprises a plurality of topically beneficial constituents; andsaid plurality of topically beneficial constituents includes a lauric-acid content, a capric ...

Methods of Diagnosing and Treating Dry Eye Syndrome and Compositions for Treating a Human Eye

In preferred the invention is directed to ocular compositions for the treatment of dry eye, methods for making such compositions, and suites comprising a plurality of different ocular compositions each having a defined composition. In preferred examples, the invention is directed to compositions comprising at least one natural oil, wherein a first member of the suite of compositions is effective in treating dry in in a first patient having a particular set of symptoms and a different second member of the suite of compositions is effective in treating dry in in a second patient having a different set of symptoms. The invention is also directed to methods of making and using the compositions, and to skin care compositions for use around the eye, such as the upper and lower eyelids having a lubricating, non-irritating base composition comprising at least one natural oil. 1. A method of diagnosing and treating dry eye syndrome comprising:testing the tears of a patient to determine whether the patient has dry eye syndrome and, if so, to determine the characteristics of the dry eye syndrome present in the eye or eyes of the patient;inquiring of the patient as to what degree of sensitivity the patient has that would affect the choice of medication to be used in treating the dry eye syndrome in the eye or eyes of the patient; andproviding, based on the testing and inquiring, a treatment composition for use in the patient's eye to treat the patient's dry eye syndrome, the treatment composition being selected from a series of different compositions comprising water and a natural oil component selected from the group consisting of jojoba oil, avocado oil, tea tree oil, coconut oil, argan, oleuroleupein, cottonseed oil, sunflower oil, maize oil, linseed oil, rapeseed oil, tea tree oil, argan oil, castor oil, soybean oil, caraway oil, rosemary oil, peppermint oil, sunflower oil, eucalyptus oil, bergamot oil, fennel oil, sesame oil, menthol oil, ginseng oil, jujube oil, okra oil; ...

THERAPEUTIC COMPOSITIONS AND USES THEREOF FOR ALLEVIATING PAIN SYSTEMS

A therapeutic composition for skin use composed of essential oils derived from natural plant sources and at least one carrier oil. The compositions are administered topically to provide pain relief. 1. A composition for skin , the composition comprising:fenugreek essential oil;almond essential oil;mint essential oil;garlic essential oil;castor essential oil; andat least one carrier oil.2. The composition of claim 1 , wherein said at least one carrier oil includes fractionated coconut oil.3. The composition of claim 1 , wherein approximately 18% of the volume of the composition is the fenugreek essential oil.4. The composition of claim 1 , wherein approximately 18% of the volume of the composition is the almond essential oil.5. The composition of claim 1 , wherein approximately 18% of the volume of the composition is the mint essential oil.6. The composition of claim 1 , wherein approximately 18% of the volume of the composition is the garlic essential oil.7. The composition of claim 1 , wherein approximately 18% of the volume of the composition is the castor essential oil.8. The composition of claim 1 , wherein approximately 10% of the volume of the composition is the at least one carrier oil.9. The composition of claim 1 , wherein approximately 18% of the volume of the composition is the fenugreek essential oil;wherein approximately 18% of the volume of the composition is the almond essential oil;wherein approximately 18% of the volume of the composition is the mint essential oil;wherein approximately 18% of the volume of the composition is the garlic essential oil;wherein approximately 18% of the volume of the composition is the castor essential oil; andwherein approximately 10% of the volume of the composition is the at least one carrier oil.10. A composition for skin use claim 1 , the composition comprising:fenugreek essential oil;almond essential oil;at least one carrier oil; andat least one additional plant-based essential oil.11. The composition of claim 10 , ...

Enteric Coated Multiparticulate Compositions With A Proteinaceous Subcoat

A method of treating a gastrointestinal disorder includes administering to a patient an effective amount of a multiparticulate dosage form including a plurality of individual spheroidal enteric coated cores having a diameter of 0.1 mm to 3 mm. The individual spheroidal enteric coated cores have (a) a core including menthol, (b) a proteinaceous subcoating over the core, and (c) an enteric coating over the proteinaceous subcoating. The multiparticulate dosage form is configured to release most of the menthol in the area of the GI tract where the inflammation is occurring. 1. A method of treating irritable bowel syndrome , the method comprising:administering to a patient having irritable bowel syndrome an effective amount of a multiparticulate dosage form including a plurality of individual spheroidal enteric coated cores having a diameter of 0.1 mm to 3 mm;the individual spheroidal enteric coated cores comprising (a) a core including menthol, (b) a proteinaceous subcoating over the core, and (c) an enteric coating over the proteinaceous subcoating; andwherein the multiparticulate dosage form is configured to release most of the menthol in a small intestine of the patient.2. The method of claim 1 , wherein the multiparticulate dosage form is configured to gradually release the menthol into the small intestine over 4 to 8 hours from passing a pyloric sphincter of the patient.3. The method of claim 1 , wherein the multiparticulate dosage form is configured to release 20% or less of the menthol into a stomach of the patient and 20% or less of the menthol into a colon of the patient.4. The method of claim 1 , wherein the effective amount is effective for relieving symptoms of irritable bowel syndrome including at least one of abdominal pain claim 1 , cramps claim 1 , and diarrhea.5. The method of claim 1 , wherein the individual spheroidal enteric coated cores comprise 10% w/w to 35% w/w menthol claim 1 , 40% w/w to 75% w/w microcrystalline cellulose claim 1 , and 2% w/w ...

SKIN SALVE FOR TREATING INTERTRIGO

The subject patent discloses a method for treating intertrigo on the underside of a female breasts which comprises (1) applying a skin salve to the underside of the female breasts, wherein the female breasts are dry, and wherein the skin salve is comprised of (i) petrolatum, (ii) from 11 weight percent to 60 weight percent beeswax, and (iii) from 0.25 weight percent to 10 weight percent peppermint oil, wherein the skin salve has a viscosity at 25° C. which is within the range of 11 Pa·s to 15 Pa·s at a shear rate of 35 l/s, and (2) allowing the skin salve to remain in contact with female breasts for a period of at least 4 hours. 1. A method for treating intertrigo on the underside of a female breasts which comprises (1) applying a skin salve to the underside of the female breasts , wherein the female breasts are dry , and wherein the skin salve is comprised of (i) petrolatum , (ii) from 11 weight percent to 60 weight percent beeswax , and (iii) from 0.25 weight percent to 10 weight percent peppermint oil , wherein the skin salve has a viscosity at 25° C. which is within the range of 11 Pa·s to 15 Pa·s at a shear rate of 35 l/s , and (2) allowing the skin salve to remain in contact with female breasts for a period of at least 4 hours.2. The method as specified in wherein the skin salve is void of water.3. The method as specified in wherein the beeswax is present in said salve at a level which is within the range of 12 weight percent to 20 weight percent.4. The method as specified in wherein the peppermint oil is present in said salve at a level which is within the range of 1 weight percent to 3 weight percent.5. The method as specified in wherein the beeswax is present in said salve at a level which is within the range of 14 weight percent to 18 weight percent.6. The method as specified in wherein the peppermint oil is present in said salve at a level which is within the range of 1.2 weight percent to 2 weight percent.7. The method as specified in wherein the beeswax ...

COMPOSITIONS AND METHODS FOR RELIEF FROM COLD SORES

The invention provides compositions and methods that relieve pain and reduce the duration of cold sore episodes to a period of at most 3 to 5 days. Specifically, the invention provides a combination of extracts of bitter orange (), yarrow () and at least one of goldenseal ()), barberry () and Chinese goldthread (); the invention may be used in the form of a cream, lipstick or other topical composition dosing format to treat and prevent cold sore episodes. In certain embodiments the compositions include further ingredients such as an analgesic natural composition from the mint genus (), a protective coat-forming substance, a substance for promoting general health of skin, a substance to modify the color of the product a substance to modify the flavor of the product, a preservative, and/or a substance to modify the texture, viscosity or mechanical strength of the composition. 2Mentha.) The topical composition of claim 1 , further comprising a natural substance from the genus3) The topical composition of claim 2 , wherein:{'i': 'Mentha', 'a) the natural substance from the genus is selected from the group consisting of menthol, spearmint oil or peppermint oil; and'}{'i': 'Mentha', 'b) the natural substance from the genus is present in an amount that is within a range of 0.015% to 8% by weight relative to the topical composition.'}4) The topical composition of claim 1 , further comprising a coat-forming substance.5) The topical composition of claim 4 , wherein the coat-forming substance is present in an amount that is within a range from 1% to 15% by weight.6) The topical composition of claim 1 , further comprising a pharmaceutically acceptable substance selected from the group consisting of flavoring compounds and food coloring compounds.7) The topical composition of claim 6 , wherein the concentration of a pharmaceutically acceptable substance selected from the group consisting of flavoring compounds and food coloring compounds is present in an amount that is within a ...

MINT MASK AND METHODS OF USE THEREOF

Provided are methods and devices useful for treating a respiratory disease or disorder involving the central or upper airways. The methods and devices deliver to central or upper airways of a subject a vapor or aerosol comprising an effective amount of an active ingredient selected from the group consisting of menthol, menthone, neomenthol, isomenthol, and menthofuran. The methods are useful for treating conditions including cough, asthma, bronchitis, and allergic rhinitis. 1. A method of treating a respiratory disease or disorder involving the central airways , comprising administering to the central airways of a subject in need thereof a vapor or aerosol comprising a therapeutically effective amount of an active pharmaceutical ingredient (API) selected from the group consisting of menthol , menthone , neomenthol , isomenthol , menthofuran , and any combination thereof.2. The method of claim 1 , wherein the API comprises menthol.3. The method of claim 1 , wherein the API is provided as volatile oil of peppermint.4. The method of claim 1 , wherein the API is administered in conjunction with a rebreathing device.5. The method of claim 4 , wherein the rebreathing device comprises a semi-porous substrate impregnated with the API.6. The method of claim 4 , wherein the rebreathing device is a mask comprising a semi-porous substrate impregnated with the API claim 4 , and the mask is constructed and arranged to fit over nose claim 4 , mouth claim 4 , or both nose and mouth of the subject.7. The method of claim 4 , wherein the rebreathing device is breath-activated.8. The method of claim 1 , wherein the vapor or aerosol is delivered to the central airways by inhalation by the subject.9. The method of claim 1 , wherein the respiratory disease or disorder involving the central airways is asthma.10. The method of claim 1 , wherein the respiratory disease or disorder involving the central airways is bronchitis.11. The method of claim 1 , wherein the respiratory disease or ...

GINKGO BILOBA EXTRACT COMPOSITE FORMULATION AND USE OF THE SAME

The present invention discloses a extract composite formulation and the use thereof, comprising: a extract, a extract, astaxanthin, , Coenzyme Q10 and American ; the extract comprises flavonoids and Ginkgolides; the extract comprises tanshinone II A, Danshensu and Salvianolic acid. The invention combines the extract, the extract, astaxanthin, , Coenzyme Q10 and American for comprehensive preparation; effectively conditions the disordered body through comprehensive nourishing and conditioning, thus truly solving the “fatigue” and supplementing vitality, and recuperating the body to a healthy state. The extract composite formulation of the invention can be widely used in patients with cardiovascular and cerebrovascular diseases, “three high symptoms”, and has a variety of functions such as anti-cancer, anti-fatigue, anti-hypoxia, anti-radiation, anti-aging and enhancing immunity. 1Ginkgo BilobaGinkgo BilobaSalvia miltiorrhizaAstragalusGinseng;. A extract composite formulation , characterized in that , comprising: a extract , a extract , astaxanthin , , Coenzyme Q10 and American{'i': Ginkgo Biloba', 'Ginkgo', 'Salvia miltiorrhiza, 'the extract comprises flavonoids and Ginkgolides, and the extract comprises tanshinone II A, Danshensu and Salvianolic acid.'}2Ginkgo BilobaGinkgo BilobaSalvia miltiorrhizaAstragalusGinseng. The extract composite formulation according to claim 1 , wherein based on the total weight claim 1 , the extract accounts for 1-60 parts claim 1 , the extract accounts for 1-60 parts claim 1 , the astaxanthin accounts for 1-50 parts claim 1 , the accounts for 1-20 parts claim 1 , the Coenzyme Q10 accounts for 1-30 parts claim 1 , and the American accounts for 1-25 parts.3Ginkgo BilobaGinkgo BilobaSalvia miltiorrhizaAstragalusGinseng. The extract composite formulation according to claim 2 , wherein based on the total weight claim 2 , the extract accounts for 35-45 parts claim 2 , the extract accounts for 18-26 parts claim 2 , the astaxanthin accounts for ...

THERAPEUTIC COMPOSITIONS

A therapeutic topical composition comprising (yarrow) extract, aloe vera, flowers, annatto seed extract, boswellia serrate extract, marigold flower extract, cetearyl olivate, cetyl myristoleate, sunflower seed oil, sorbitan olivate, turmeric root extract, methylsulfonylmethane (MSM), emu oil, devil's claw root extract, yerba mate leaf extract, magnesium sulfate, peppermint oil, menthol, skullcap root extract, vitamin E, and root extract useful for treatment of localized pain, inflammation, and/or swelling, and methods for making and using the composition. 1arnica montanayucca) A topical therapeutic composition which comprises 0.01-0.04 wt. % yarrow extract , 1-30 wt. % aloe vera , 0.05-0.8 wt % extract , 0.5-10 wt. % beeswax , 0.01-0.2 wt. % annatto seed extract , 0.05-0.2 wt. % boswellia serrate extract , 0.05-0.2 wt. % marigold flower extract , 0.5-2 wt. % carpylic/capric triglyceride , 1-4 wt. % cetearyl olivate , 0.01-15 wt. % cetyl myristoleate , 0.05-1.5 wt. % turmeric root extract , 1-20 wt. % methylsulfonylmethane (MSM) , 0.01-20 wt. % emu oil , 0.3-1.5 wt. % gluconolactone , 1-8 wt. % glycerin , 1-10 wt. % glyceryl stearate SE , 0.01-0.8 wt. % devil's claw root extract , 0.1-2 wt. % sunflower seed oil , 0.01-0.2 wt. % yerba mate leaf extract , 1-30 wt. % magnesium sulfate , 0.03-3 wt. % peppermint oil , 1.25-10 wt. % menthol , 0.01-0.2 wt. % skullcap root extract , 0.1-0.6 wt. % sodium benzoate , 0.5-4 wt. % sorbitan olivate , 1-6 wt. % steric acid , 0.05-2 wt. % vitamin E , 0.1-2.5 wt. % xanthan gum , and 0.01-0.4 wt. % root extract.2arnica montanayucca) The composition of which comprises 0.01-0.03 wt. % yarrow extract claim 1 , 4-6 wt. % aloe vera claim 1 , 0.05-0.15 wt % extract claim 1 , 0.5-2 wt. % beeswax claim 1 , 0.01-0.1 wt. % annatto seed extract claim 1 , 0.05-0.15 wt. % boswellia serrate extract claim 1 , 0.05-0.15 wt. % marigold flower extract claim 1 , 0.75-1.25 wt. % carpylic/capric triglyceride claim 1 , 1.5-2.5 wt. % cetearyl olivate claim ...

HERBAL SUPPLEMENTS AND METHODS OF USE THEREOF

In one embodiment, the present application provides an herbal supplement and method for treating bloating, constipation and/or weight gain in a human subject comprising orally administering to a subject in need thereof an effective amount of the herbal supplement comprising a red quebracho extract. In other embodiments, the supplement may additionally include a triterpenoid saponin, an anti-spasmodic agent, or both. 1. A method for treating bloating , constipation and/or weight gain in a human subject , comprising:orally administering to a human subject in need thereof an herbal supplement comprising condensed tannins in an amount effective to reduce bloating, constipation and/or weight gain in a human subject.2. The method of claim 1 , wherein the condensed tannins are administered from a red quebracho extract in the herbal supplement.3. The method of claim 2 , wherein the herbal supplement further comprises an herbal composition comprising an anti-spasmodic agent.4. The method of claim 3 , wherein the anti-spasmodic agent is provided in the form of a peppermint oil.5. The method of claim 2 , wherein the herbal supplement further comprises an herbal composition comprising a triterpenoid saponin.6AesculusSatindus. The method of claim 5 , wherein the triterpenoid saponin is provided in the form of an or species plant extract.7. The method of claim 5 , wherein the herbal supplement further comprises an herbal composition comprising an anti-spasmodic agent.8Aesculus hippocastanum. The method of claim 7 , wherein the herbal supplement is formulated in a dosage form that comprises between about 20 to 500 mg of red quebracho extract; between about 0.1 to about 2 mg of plant extract; and between about 0.05 to about 1 ml of peppermint oil.9. The method of claim 1 , wherein the herbal supplement further comprises a nutraceutically acceptable carrier.10. The method of claim 1 , wherein the human subject suffers from irritable bowel syndrome claim 1 , functional constipation ...

NASAL DEVICES

A delivery device capable of being mounted or attached outside the nose to a nasal device, wherein said delivery device is adapted to deliver, spread or emit inhalable compositions or substances such as inhalable fumes from said delivery device to the nasal passages of the nose so as to be inhaled by the user, such as during respiration, when in use. Nasal devices such as nasal dilator devices comprising same, and cases for storing and housing same. 1. A nasal device for facilitating or enhancing respiration of a user , comprising:a delivery device for providing an inhalable composition for inhalation by the user, the delivery device comprising a holder for a source of the inhalable composition to be received and/or supported on a frame member of the nasal device such that the source of the inhalable composition, when provided in the holder in use, is located outside of and adjacent to at least one nostril of the user, wherein the source is configured to emit or diffuse the inhalable composition for inhalation by the user.2. A nasal device according to claim 1 , wherein the holder is provided on one or more frame member of the nasal device and comprises at least one of:a receptacle configured to be filled with the source of the inhalable composition;a substrate configured to be filled with the source of the inhalable composition; andmeans for mounting or attaching a receptacle or a substrate configured to be filled with the source of the inhalable composition.3. A nasal device according to claim 2 , wherein the substrate is an absorbent substrate.4. A nasal device according to or claim 2 , wherein the means for mounting or attaching the receptacle or substrate forms a recess for receiving and accommodating or housing the receptacle or substrate on one or more frame members of the nasal device.5. A nasal device according to claim 4 , wherein the means for mounting or attaching the receptacle or substrate forms a recess for removably receiving and accommodating or ...

TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF

The invention is directed to a topical composition comprising one or more topical active ingredients, one or more nonionic surfactants and one or more viscosity enhancers. The invention is further directed to a method of treating topical conditions comprising applying a composition of the present invention to a subject in need thereof. 1. A topical composition comprising one or more topical active ingredients , one or more nonionic surfactants and one or more viscosity enhancers.2. The composition of claim 1 , wherein the one or more topical active ingredients is selected from the group consisting of a topical analgesic claim 1 , a hemorrhoid treatment compound claim 1 , an acne treatment compound claim 1 , an anti-wrinkle compound claim 1 , an anti-scar compound and mupirocin.3. The composition of claim 1 , wherein the one or more topical active ingredients is one or more topical analgesics selected from the group consisting of lidocaine claim 1 , lidocaine hydrochloride claim 1 , menthol claim 1 , camphor claim 1 , methyl salicylate claim 1 , cajuput oil claim 1 , dementholised mint oil and clove oil.4. The composition of claim 1 , wherein the one or more topical active ingredients is one or more hemorrhoid treatment compounds selected from the group consisting of hydrocortisone claim 1 , phenylephrine hydrochloride and pramoxine hydrochloride.5. The composition of claim 1 , wherein the one or more topical active ingredients is one or more acne treatment compounds selected from the group consisting of benzoyl peroxide claim 1 , salicylic acid claim 1 , azelaic acid claim 1 , dapsone claim 1 , resorcinol erythromycin and clindamycin.6. The composition of claim 1 , wherein the one or more topical active ingredients is one or more anti-wrinkle compounds selected from the group consisting of retinol claim 1 , tretinoin claim 1 , isotretinoin claim 1 , alitretinoin claim 1 , etretinate claim 1 , acitretin claim 1 , adapalene and tazarotene claim 1 , vitamin C claim 1 , ...

Compositions and Methods for Joint Health

The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of modulating joint inflammation, joint pain, joint stiffness, cartilage degradation, or improving mobility, range of motion, flexibility, joint physical function, or any combination thereof. Such a mixture of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both can optionally be used in combination with other joint management agents, such as non-steroidal anti-inflammatory agents/analgesics, COX/LOX inhibiting agents, glucosamine compounds, neuropathic pain relief agents, or the like.

Eye-refreshing agent to eliminate and alleviate eye fatigue and discomfort

An eye-refreshing agent, the raw materials of which include mung bean germs, eucalyptus leaves, mint leaves, clove leaves, camphor leaves and borneol. The plant cells thereof are respectively subjected to crushing, low-temperature freezing and centrifugation and sound membrane separation to prepare a water-soluble preparation. The preparation can prevent and alleviate visual fatigue and accelerate metabolism of the eye skin cells, and also has the effect of alleviating and improving eye bags and eye pseudo-wrinkles caused by eye fatigue.

SKIN TEMPERATURE ELEVATING AGENT, AND COSMETIC COMPOSITION, FOOD AND SUNDRY ARTICLE CONTAINING THE SAME

Disclosed here is a method for elevating skin temperature comprising administering to a subject in need thereof a composition comprising an effective amount of one or more compounds selected from the group consisting of dihydro-β-ionol and 4-methoxystyrene. Also disclosed is a method for elevating skin temperature comprising administering to a subject in need thereof a composition comprising an effective amount of one or more compounds selected from the group consisting of dihydro-β-ionol, 4-methoxystyrene, clary sage extract, Japanese peppermint extract, juniper berry extract, and geraniol. 1. A method for elevating skin temperature comprising administering to a subject in need thereof a composition comprising an effective amount of one or more compounds selected from the group consisting of dihydro-β-ionol and 4-methoxystyrene.2. The method of claim 1 , wherein the composition comprises dihydro-β-ionol.3. The method of claim 1 , wherein the composition comprises 4-methoxystyrene.4. The method of claim 1 , wherein the composition further comprises a dilution agent.5. A method for elevating skin temperature comprising administering to a subject in need thereof a composition comprising an effective amount of one or more compounds selected from the group consisting of dihydro-β-ionol claim 1 , 4-methoxystyrene claim 1 , clary sage extract claim 1 , Japanese peppermint extract claim 1 , juniper berry extract claim 1 , and geraniol.6. The method of claim 1 , wherein the composition comprises clary sage extract.7. The method of claim 1 , wherein the composition comprises Japanese peppermint extract.8. The method of claim 1 , wherein the composition comprises juniper berry extract.9. The method of claim 1 , wherein the composition comprises geraniol.10. The method of claim 1 , wherein the composition further comprises a dilution agent. This application is a Continuation of U.S. application Ser. No. 13/700,895, which is a National Stage application of PCT/JP2011/002954, ...

PLANT EXTRACTS FOR IMPROVING COGNITIVE FUNCTION

Extracts of plants of the Lamiaceae family, including the genus, are shown to have a positive impact on overall cognitive health, including improvements in memory, reasoning, attention/concentration, planning, mood, sleep and associated behaviors. 1. A method to enhance , improve or sustain cognitive health and/or function in a mammal , comprising administering an efficacious amount of an extract of a plant of the Lamiaceae family , wherein the primary active ingredients are rosmarinic acid and plant polyphenols.2. (canceled)3. The method of claim 1 , wherein the plant is selected from the group consisting of basil claim 1 , mint claim 1 , sage claim 1 , savory claim 1 , marjoram claim 1 , oregano claim 1 , thyme claim 1 , lavender claim 1 , spearmint claim 1 , and rosemary.4Mentha. The method of claim 1 , wherein the plant is selected from the genus.5. The method of claim 1 , wherein the extract comprises at least 8% rosmarinic acid by weight.6. The method of claim 1 , wherein the efficacious amount is between 0.01 and 50 mg/kg/day.7. (canceled)8. The method of claim 1 , wherein the extract is administered chronically.9. (canceled)10. The method of claim 1 , wherein administration of the extract improves learning claim 1 , executive function claim 1 , memory claim 1 , mood claim 1 , or sleep.11. The method of claim 1 , wherein administration of the extract improves quality of life.12. (canceled)13. (canceled)14. (canceled)15. (canceled)16. (canceled)17. (canceled)18. (canceled)19. (canceled)20. (canceled)21. (canceled)22. (canceled)23. (canceled)24. (canceled)25. A method for improving mood in a mammal comprising administering an efficacious amount of an extract of a plant of the Lamiaceae family claim 1 , wherein the primary active ingredients are rosmarinic acid and plant polyphenols.26. (canceled)27. The method of claim 25 , wherein the plant is selected from the group consisting of basil claim 25 , mint claim 25 , sage claim 25 , savory claim 25 , marjoram ...

Moisturizing gel for preventing or healing injured nipples or areola in my mammalian females

The present invention provides a composition and method for preventing or healing injured nipples or areolas in mammalian females utilizing components of water, peppermint oil and poloxamer in a synergistic ratio 1. A dermatological composition for preventing or healing injured nipples or areolas in mammalian females , comprising:Water;Peppermint Oil;Poloxamer 407; said composition in a synergistic ration ofH2O 1:Poloxamer 407 0.20-0.25:Peppermint Oil 0.0020-0.0027.2. The composition of wherein the synergistic ratio isH2O 1:Poloxamer 407 0.23-0.24:Peppermint Oil 0.0023-0.00253. The composition of wherein the synergistic ratio isH2O 1:Poloxamer 407 0.22-0.24:Peppermint Oil 0.0024-0.00254. A method of preparing a dermatological composition as recited in used as a skin cream or balm claim 1 , said comprising the following steps:placing 10 μm of Poloxamer 407, N.F. into a 4 oz. glass mortar;adding and triturating 20 mL of cold Water for Injection (WATER USP) is with a pestle until uniform;scraping of the pestle will be necessary with the wetted Poloxamer being returned to the mortar;adding and triturating an additional 20 mL of cold WATER USP is added and triturated again until uniform. 2 mL of drawing Peppermint Oil, USP into a glass syringe and adding to the content of the mortar and mixed until uniform;adding an additional 30 ml of cold WATER USP until the mixture becomes smooth and milky in appearance;transferring the mixture to a one liter, wide-mouth bottle with screw cap;adding 60 mL cold WATER USP to the mortar and swirling with the pestle to rinse, subsequently adding to the one liter bottle;adding an additional 700 mL of cold WATER USP is added to the one liter bottle, a cap is secured tightly one the one liter bottle, and shaken vigorously for 30 seconds;adding 220 μm of Poloxamer 407 to the one-liter bottle, the cap secured tightly, and shaken vigorously for 30 seconds;placing the one liter bottle into a 4 degree C. refrigerator for one hour;removing the ...

TOPICAL ANALGESIC

One or more of embodiments of the present invention generally concern a topical analgesic, which can be used to treat painful skin ailments. The topical analgesic can comprise 8 to 40 weight percent of methanol and 0.05 to 5 weight percent of one or more essential oils selected from the group consisting of spearmint essential oil, lavender essential oil, eucalyptus essential oil, lemon essential oil, peppermint essential oil, basil essential oil, and wintergreen essential oil. Furthermore, the topical analgesic can comprise less than 1 weight percent of parabens and less than 1 weight percent of gluten. In addition, the topical analgesic can meet one or more of the following criteria: (i) the topical analgesic comprises less than 10 weight percent of methyl salicylate and (2) the topical analgesic comprises less than 3 weight percent of camphor. 1. A topical analgesic comprising:8 to 40 weight percent menthol; and0.05 to 5 weight percent of one or more essential oils selected from the group consisting of spearmint essential oil, lavender essential oil, eucalyptus essential oil, lemon essential oil, peppermint essential oil, basil essential oil, and wintergreen essential oil,wherein said topical analgesic comprises less than 1 weight percent parabens and less than 1 weight percent gluten,wherein said topical analgesic meets one or more of the following criteria—(i) said topical analgesic comprises less than 10 percent methyl salicylate,(ii) said topical analgesic comprises less than 3 percent camphor.2. The topical analgesic of claim 1 , wherein said topical analgesic comprises menthol in an amount in the range of from 10 to 25 weight percent.3. The topical analgesic of claim 1 , wherein said topical analgesic comprises at least three of the following essential oils: spearmint essential oil claim 1 , lavender essential oil claim 1 , eucalyptus essential oil claim 1 , lemon essential oil claim 1 , peppermint essential oil claim 1 , basil essential oil claim 1 , and ...

CANNABINOID AND MENTHOL GUM AND LOZENGE COMPOSITIONS AND METHODS

The present disclosure relates to chewing gum or lozenge with cannabinoids and menthol including a liquid-filled chewing gum or lozenge with a chewing gum base shell or lozenge candy shell enclosing an internal void therein and a liquid filling in the void, the liquid-filled chewing gum or lozenge including cannabinoids and menthol. 1. A chewing gum or lozenge product , comprising:at least one cannabinoid is in an amount of from about 0.1 wt % to about 10 wt %;an effective amount of menthol.2. The chewing gum or lozenge product of claim 1 , wherein the at least one cannabinoid includes full spectrum hemp oil.3. The chewing gum or lozenge product of claim 1 , wherein the at least one cannabinoid includes less than 0.3 wt % THC.4. The chewing gum or lozenge product of claim 1 , wherein the menthol is in an amount of from about 0.1 wt % to about 14 wt %.5. The chewing gum or lozenge product of claim 1 , further including at least one of an anti-oxidant claim 1 , a colorant claim 1 , a flavoring claim 1 , a flavor enhancer claim 1 , a preservative claim 1 , a salivary stimulating agent claim 1 , a cooling agent claim 1 , a co-solvents claim 1 , an emollient claim 1 , a bulking agent claim 1 , an anti-foaming agent claim 1 , a surfactant claim 1 , a sweetening agent claim 1 , a filler and a taste-masking agent.6. The chewing gum or lozenge product of claim 5 , wherein the filler is in an amount of from about 15 wt % to about 40 wt % and the sweetening agent is in an amount of from about 0.005 wt % to about 5 wt %.7. The chewing gum or lozenge product of claim 5 , wherein the salivary stimulating agent is citric acid in an amount of from about 0.1 wt % to about 10 wt %.8. The chewing gum or lozenge product of claim 1 , further including an exterior sugar coating.9. A filled chewing gum or lozenge product including a shell enclosing an internal void therein and a filling in the void claim 1 , the filled chewing gum or lozenge product comprising:full spectrum hemp oil in an ...

AUTISM IMPROVING AGENT AND AUTISM IMPROVING TEA

Provided is an improving agent that is more suitable to improvement of autism, the agent having reduced side effects thanks to the suppression of the immunological factors. An autism improving agent is provided that is characterized in that the inventive agent contains celery seed, wheat, lemon balm, mint, fenugreek seed, laurel, brown sugar powder and rosemary and that the agent has an effect of improving the symptoms relative to autism. 1stevia,. An autism improving agent characterized in that the inventive agent contains celery seed , wheat , lemon balm , mint , fenugreek seed , laurel , brown sugar powder and rosemary and that the agent has an effect of improving the symptoms relative to autism.2stevia,. The autism improving agent according to claim 1 , characterized in that it contains 2 to 8 grams of celery seed claim 1 , 0.5 to 4 grams of wheat claim 1 , 2 to 8 grams of lemon balm claim 1 , 0.5 to 3 grams of mint claim 1 , 1 to 6 grams of fenugreek seed claim 1 , 0.5 to 4 grams of 1 to 6 grams of laurel claim 1 , 0.1 to 2 grams of brown sugar powder claim 1 , and 1 to 6 grams of rosemary.3stevia,. An autism improving tea characterized in that the inventive agent contains celery seed claim 1 , wheat claim 1 , lemon balm claim 1 , mint claim 1 , fenugreek seed claim 1 , laurel claim 1 , brown sugar powder and rosemary and that the agent has an effect of improving the symptoms relative to autism.4stevia,. The autism improving tea according to claim 3 , characterized in that it contains 2 to 8 grams of celery seed claim 3 , 0.5 to 4 grams of wheat claim 3 , 2 to 8 grams of lemon balm claim 3 , 0.5 to 3 grams of mint claim 3 , 1 to 6 grams of fenugreek seed claim 3 , 0.5 to 4 grams of 1 to 6 grams of laurel claim 3 , 0.1 to 2 grams of brown sugar powder claim 3 , and 1 to 6 grams of rosemary. The present invention relates to an autism improving agent, autism improving tea and a producing method thereof, and in particular, to a more effective autism improving agent ...

Compositions and Methods for Treating and Preventing Helicobacter Pylori Infections

The present invention provides compositions and methods for treating subject infected with . The invention utilizes natural supplement compositions comprising a blend of essential oils, as well as proton-pump inhibitors and biosurfactants. Advantageously, the present invention can lead to simultaneous improvement of diseases, disorders and conditions caused by infection, reduction in the occurrence of infections, and reduction in the development of antibiotic-resistant strains of the bacteria. 2. The composition of claim 1 , further comprising a proton-pump inhibitor (PPI).3. The composition of claim 2 , wherein the PPI is omeprazole.4. The composition of claim 1 , further comprising a biosurfactant.5. The composition of claim 4 , wherein the biosurfactant is a sophorolipid (SLP).6Satureja bachtiarica. A supplement composition consisting essentially of an essential oil blend comprising lemongrass oil claim 4 , garlic oil claim 4 , oregano oil claim 4 , oil claim 4 , and ginger oil claim 4 ,a PPI, anda biosurfactant.7. The composition of claim 6 , wherein the PPI is omeprazole.8. The composition of claim 6 , wherein the biosurfactant is a sophorolipid (SLP).910-. (canceled)11Helicobacter. A method for treating and/or preventing infection in a subject claim 1 , wherein the method comprises administering to the subject a therapeutically-effective amount of the composition of .12. The method of claim 11 , further comprising administering a PPI to the subject.13. The method of claim 12 , wherein the PPI is omeprazole.14. The method of claim 11 , further comprising administering a biosurfactant to the subject.15. The method of claim 14 , wherein the biosurfactant is a purified sophorolipid (SLP).16. The method of claim 11 , wherein the supplement composition is administered to the subject orally.17. The method of claim 11 , further comprising diagnosing the subject with an Helicobater infection prior to administering the supplement composition.18H. bilis, H. bizzozeronii, ...

COMPOSITION FOR TREATING WOUNDS AND OTHER DERMATOLOGICAL CONDITIONS

The present invention is directed to a composition that is suitable for the treatment of wounds and other dermatological conditions. The composition of the present invention comprises an anesthetic agent; an antipruritic agent; a mitotic agent; vitamin D or a derivative thereof; at least one of peppermint oil and thyme oil; one or more antioxidant agents; and a pharmaceutically acceptable carrier. The composition may further comprise one or more humectants and/or one or more emollients. 1. A composition comprising:an anesthetic agent;an antipruritic agent;a mitotic agent;vitamin D or a derivative thereof;at least one of peppermint oil and thyme flower leaf oil;one or more antioxidant agents; anda pharmaceutically acceptable carrier.2. The composition of claim 1 , wherein the anesthetic agent is selected from the group consisting of benzocaine claim 1 , lidocaine claim 1 , chloroprocaine claim 1 , mepivacaine claim 1 , bupivacaine claim 1 , articaine claim 1 , etidocaine claim 1 , levobupivacaine claim 1 , tetracaine claim 1 , prilocaine claim 1 , ropivacaine claim 1 , cocaine claim 1 , oxyprocaine claim 1 , hexylcaine claim 1 , dibucaine claim 1 , piperocaine claim 1 , pramoxine claim 1 , hydrocortisone claim 1 , calamine claim 1 , butamben claim 1 , tetracaine claim 1 , proxymetacaine claim 1 , procaine and pharmaceutically acceptable acids claim 1 , bases and salts thereof.3. The composition of claim 1 , wherein the anesthetic agent is benzocaine.4. The composition of claim 1 , wherein the antipruritic agent is resorcinol claim 1 , crotaminton cream claim 1 , chlorphenesin claim 1 , or menthol.5. The composition of claim 1 , wherein the antipruritic agent is selected from the group consisting of a topical corticosteroid claim 1 , a calcineurin inhibitor claim 1 , a topical antihistamine claim 1 , and a topical neuromodulator.6. The composition of claim 1 , wherein the mitotic agent is a retinoid or derivative thereof selected from the group consisting of retinol ...

Herbal Tea Products and Methods

An herbal tea product is provided to provide relief from lung and breathing conditions such as asthma. The herbal tea product may include oregano, peppermint, OSHA root, lungwort, eucalyptus, plantain leaf, chaparral, elecampane, lobelia, sage, licorice root, and thyme. The herbal ingredients may be included in equal amounts, such as 5 ounces. The OSHA root, elecampane, and/or licorice root may be crushed. Methods of making and using the herbal tea product are also disclosed. The herbal tea product may be placed into tea bags, and prepared for human consumption by placing the tea bag with herbal tea product in hot water that has been brought to a boil. The herbal tea product may be consumed in appropriate amounts, such as 16 ounces, twice a day for two weeks, and then once a day thereafter.

METHOD TO PREPARE A THERAPEUTIC BALM

A method to prepare a therapeutic balm is disclosed. A first phase solution is prepared in an oak barrel using a grain neutral spirit. The first phase is mixed for 10 minutes per day for a month to prepare a second phase solution. The second phase solution is filtered at least twice to prepare a filtrate. The filtrate and third phase components are mixed to prepare a third phase solution. The third phase solution is mixed with a distilled wine liquor to prepare a fourth phase solution. The fourth phase solution is mixed at least twice a day for a month to prepare a fifth phase solution. The fifth phase solution is mixed with cranberry juice, pomegranate juice, and raspberry juice to prepare a sixth phase solution. The sixth phase solution is stored in a ceramic bottle for a least six months at room temperature to prepare a therapeutic balm.

SYNERGISTIC COMPOSITION OF FOOD-BASED AND ORGANIC NUTRIENTS AND METHODS FOR USE AND MANUFACTURE

This application pertains generally to nutritional supplements comprising organic nutrients for consumption by a mammalian subject that supports and protects the immune system in a synergistic and complex way. 1Avena sativaAstragalusBrassica oleraceaGanoderma lucidumCurcuma longaPolygonum cupsidatumVitis rotundifoliaPetroselinum crispumCamellia sinensisMentha piperita L. A composition comprising an admixture of nutraceutical components selected from beta-glucans from oats (); extract; Broccoli sprouts extract (); (Reishi Mushroom) extract; extract; Trans-Resveratrol from ; grape seed extract from ; Apigenin from Green parsley extract () , green tea extract comprising epigallocatechin-3-gallate (EGCG) from ; Aloe vera extract; peppermint extract from ; and , Vitamin D3 (Cholecaliferol).2AstragalusBrassica oleraceaGanoderma lucidumCurcuma longaPolygonum cupsidatumVitis rotundifoliaPetroselinum crispumCamellia sinensisMentha piperita L. The composition of comprising 110-150 mg of beta-glucans from oats; about 80-120 mg of extract; about 80-120 mg of extract; about 70-90 mg of (Reishi Mushroom) extract; about 40-60 mg of extract; about 30-50 mg of Trans-Resveratrol from ; about 30-50 mg of grape seed extract from ; about 30-50 mg of apigenin from Green parsley extract () claim 1 , about 20-40 mg of green tea extract comprising epigallocatechin-3-gallate (EGCG) from ; about 10-20 mg of Aloe vera extract; about 5-15 mg peppermint extract from ; and claim 1 , about 150-250 IU or 1-5 microgram of Vitamin D3 (Cholecaliferol).3AstragalusBrassica oleraceaGanoderma lucidumCurcuma longa. The composition of comprising about 117-143 mg of the beta-glucans; about 80-120 mg of the extract; about 90-110 mg of the extract; about 80 mg of the (Reishi Mushroom) extract; about 45-55 mg of the extract; about 36-44 mg of the Trans-Resveratrol; about 36-44 mg of the grape seed extract; about 36-44 mg of the green parsley extract; about 27-33 mg of the green tea extract; about 13.5-16.5 mg ...

Multiparticulate L-Menthol Formulations and Related Methods

A pharmaceutical dosage form includes an effective amount of L-menthol for treating a gastrointestinal disorder. The L-menthol is within a plurality of particulates having a core including crystalline L-menthol dissolved in a terpene-based essential oil. A proteinaceous coating of a continuous film of proteinaceous material is over the core.

METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS

Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed. 120-. (canceled)21. A method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject , said method comprising:depriving a population of proliferating bacteria of nutrient(s) sufficiently to inhibit the growth of said bacteria in the small intestine, and thereby at least partially eradicating SIBO in the human subject.22. The method of claim 21 , wherein the SIBO-caused condition is selected from the group consisting of irritable bowel syndrome claim 21 , fibromyalgia claim 21 , chronic pelvic pain syndrome claim 21 , chronic fatigue syndrome claim 21 , depression claim 21 , impaired mentation claim 21 , impaired memory claim 21 , halitosis claim 21 , tinnitus claim 21 , sugar craving claim 21 , autism claim 21 , attention deficit/hyperactivity disorder claim 21 , drug sensitivity claim 21 , an autoimmune disease claim 21 , and Crohn's disease.23. The method of claim 21 , wherein the SIBO-caused condition is irritable bowel syndrome.24. The method of claim 21 , wherein depriving the population of proliferating bacteria of nutrient(s) comprises in the presence of SIBO in the human subject claim 21 , causing the subject to consume claim 21 , ...

AQUEOUS IONIC SOLUTION CONTAINING SEAWATER AND AT LEAST ONE COMPOUND THAT IS ORIGINALLY IMMISCIBLE WITH SEA WATER

The invention relates to an aqueous ionic solution, particularly for nasal use, including: at least one seawater solution having an osmolality of between 290 mOsm/kg and 400 mOsm/kg in a weight proportion of between about 30 and 98 wt % relative to the total weight of the composition; at least one cationic phospholipid of natural origin in a weight proportion of between about 0.01 and 5 wt % relative to the total weight of the composition; and at least one compound, which is originally immiscible with said seawater solution, in a weight proportion of between 0.01 and 10 wt % relative to the total weight of the composition. 1. Aqueous ionic solution , in particular intended for nasal use , comprising at least:a solution based on seawater having an osmolarity lying, for an isotonic solution, between 250 mOsm/kg and 350 mOsm/kg or, for a hypertonic solution, an osmolarity above 350 mOsm/kg, in a proportion by mass lying between approximately 25% and 98% with respect to the total mass of said aqueous ionic solution,at least one cationic phospholipid of natural origin in a proportion by mass lying between approximately 0.01% and 5% with respect to the total mass of said aqueous ionic solution,at least one compound originally immiscible with said solution based on seawater in a proportion by mass lying between approximately 0.01% and 10% with respect to the total mass of said aqueous ionic solution.2. Aqueous ionic solution according to claim 1 , characterised in that it comprises at least:said solution based on seawater having an osmolarity of between 290 mOsm/kg and 350 mOsm/kg for an isotonic solution or an osmolarity greater than 350 mOsm/kg for a hypertonic solution, in a proportion by mass between approximately 90% and 98% with respect to the total mass of said aqueous ionic solution,said at least one cationic phospholipid of natural origin, in a proportion by mass of between approximately 0.10% and 0.20% with respect to the total mass of said aqueous ionic solution ...

HERBAL SUPPLEMENTS AND METHODS OF USE THEREOF

In one embodiment, the present application provides an herbal supplement and method for treating bloating, constipation and/or weight gain in a human subject comprising orally administering to a subject in need thereof an effective amount of the herbal supplement comprising a red quebracho extract. In other embodiments, the supplement may additionally include a triterpenoid saponin, an anti-spasmodic agent, or both. 1. A method for treating bloating , constipation and/or weight gain in a human subject , comprising:orally administering to a human subject in need thereof an effective amount of a herbal supplement comprisinga red quebracho extract;an herbal composition comprising a triterpenoid saponin; andan anti-spasmodic agent, wherein the red quebracho extract is present in the herbal supplement in an amount between about 0.5% to about 75% by weight of the total supplement, wherein the herbal composition is present in the herbal supplement in an amount between about 10% to about 90% by weight of the total supplement, wherein the anti-spasmodic agent is present in the herbal supplement in an amount between about 2% to about 70% by weight of the total supplement.2. (canceled)3. (canceled)4. The method of claim 1 , wherein the anti-spasmodic agent is provided in the form of a peppermint oil.5. (canceled)6AesculusSatindus. The method of claim 1 , wherein the triterpenoid saponin is provided in the form of an or species plant extract.7. (canceled)8Aesculus hippocastanum. The method of claim 1 , wherein the herbal supplement is formulated in a dosage form that comprises between about 20 to 500 mg of red quebracho extract; between about 0.1 to about 2 g of plant extract; and between about 0.05 to about 1 ml of peppermint oil.9. The method of claim 1 , wherein the herbal supplement further comprises a nutraceutically acceptable carrier.10. The method of claim 1 , wherein the human subject suffers from irritable bowel syndrome claim 1 , functional constipation claim 1 , ...

Method and product for headache relief

A novel product for headache relief and use of the product to treat headaches is disclosed herein. The product may be applied topically, and may be used for acute treatment of headaches to provide a safe, effective, and natural alternative to traditional therapies used to treat acute headache syndromes. The product comprises one or more herbal therapeutic agents. In some embodiments, the one or more herbal therapeutic agents may be combined with allopathic or other traditional headache therapies. In preferred embodiments, the product is applied to select myofascial trigger points. (MTPs) on the temporal, frontal, mastoid, and cervical regions. The product may be available over-the-counter or otherwise may be available without a physician's prescription.

Volatile Distillate By-Product of Mint Oil That Promotes Absorption and/or Bioavailability of Compounds of Bio-Medical and Nutritional Interest

Disclosed is an adjuvant for improving the bioavailability of bioactive compositions. The adjuvant is prepared from a byproduct of mint flavor production. In vitro and in vivo testing confirms effectiveness. The adjuvant contains a mixture of compounds which is effective to improve the oral bioavailability of a bioactive composition normally having limited absorptivity, and it comprises a mixture of nonpolar compounds and compounds with some polar characteristics. In preferred form the nonpolar compounds comprise compounds selected from a group that includes terpene hydrocarbons and terpene derivatives and the compounds with some polar characteristics comprise compounds selected from a group that includes aldehydes, alcohols and ketones. The preferred compositions will have a ratio of nonpolar compounds and compounds with some polar characteristics is within the range of from 5:1 to 20:1. The adjuvants can enhance delivery of CoQ10 and other bioactive compositions, such as carotenoids (e.g., β-carotene), curcuminoids, lycopene, resveratrol, flavonoids and other phenolic compounds, organosulfur compounds, saponins, sterols, stanols, and mixtures of at least two of these, to the interior cellular environment, including organelles, such as the mitochondria.

Edible Product Comprising Reconstituted Plant Material

The present invention relates to an edible product, which comprises a fibrous plant product and a plant extract applied thereto. Further, the invention relates to a corresponding method for producing said edible product and its use in at least one of food, food supplement, medicinal, cosmetic, well-being, nutraceutical or phytotherapeutical applications. The plants used may be all plants comprising one or more substances of interest for an edible product. 136.-. (canceled)37. A fibrous material comprising:a reconstituted cocoa shell material comprising (1) extracted cocoa shell fibers combined with (2) cellulosic fibers.38. A fibrous material as defined in claim 37 , wherein the reconstituted cocoa shell material contains water solubles in an amount of less than about 50% by weight.39. A fibrous material as defined in claim 37 , wherein the reconstituted cocoa shell material contains water solubles in an amount of less than about 30% by weight.40. A fibrous material as defined in claim 37 , wherein the reconstituted cocoa shell material contains water solubles in an amount of about 5% by weight to about 20% by weight.41. A fibrous material as defined in claim 37 , wherein the cellulosic fibers comprise wood pulp fibers.42. A fibrous material as defined in claim 37 , wherein the cellulosic fibers comprise flax fibers claim 37 , hemp fibers claim 37 , abaca fibers claim 37 , softwood fibers claim 37 , hardwood fibers claim 37 , bamboo fibers claim 37 , coconut fibers claim 37 , ramie fibers claim 37 , jute fibers or mixtures thereof.43. A fibrous material as defined in claim 37 , wherein the cellulosic fibers are present in the reconstituted cocoa shell material in a weight ratio to the cocoa shell fibers of from about 20/80 to about 80/20.44. A fibrous material as defined in claim 37 , wherein the cellulosic fibers are present in the reconstituted cocoa shell material in a weight ratio to the cocoa shell fibers of from about 20/80 to about 40/60.45. A fibrous ...

PHARMACEUTICAL FORMULATION

The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant. 1. A method of treating multiple sclerosis in a patient in need thereof , wherein the method comprises administering to the patient a liquid pharmaceutical formulation comprising in a 1 mL volume: 22.5-27.5 mg/mL of delta-9-tetrahydrocannabinol (THC) based on amount of cannabinoid in a botanical drug substance , 22.5-27.5 mg/mL of cannabidiol (CBD) based on amount of cannabinoid in a botanical drug substance , 0.5 mL/mL of propylene glycol , 0.0005 mL/mL of peppermint oil , and anhydrous ethanol to 1 mL.2. The method of claim 1 , wherein the liquid pharmaceutical formulation comprises 22.5-27.5 mg/mL of THC based on amount of cannabinoid in a botanical drug substance claim 1 , 25 mg/mL of CBD based on amount of cannabinoid in a botanical drug substance claim 1 , 0.5 mL/mL of propylene glycol claim 1 , 0.0005 mL/mL of peppermint oil claim 1 , and anhydrous ethanol to 1 mL.3. The method of claim 2 , wherein the liquid pharmaceutical formulation is administered to the patient by sub-lingual application.4. The method of claim 2 , wherein the liquid pharmaceutical formulation is administered to the patient by buccal application.5. The method of claim 2 , wherein the liquid pharmaceutical formulation is administered via a pump-action spray.6. A method of treating spasms associated with multiple sclerosis in a patient in need thereof claim 2 , wherein the method comprises administering to ...

TOPICAL COMPOSITION

A topical composition is provided that includes at least three plant extracts selected from the group consisting of: lavender, calendula, rosemary, peppermint, myrrh, frankincense, helichrysum and aloe. The plant extracts in are dissolved or suspended in a carrier. The topical composition in some embodiments has each of said at least three plant extracts present in an amount of from 0.1 to 60 total weight percent of an inventive composition, with the total amount of plant extracts being between 2 and 90 total weight percent. A method of treating irradiated skin includes the application of such a composition to skin after medical irradiation, then allowing sufficient time for the skin to heal. A method of inhibiting radiation dermatitis includes the application of such a composition to skin prior to medical irradiation, then irradiating the skin ionizing radiation. 1. A topical composition , comprising:at least three plant extracts selected from the group consisting of: lavender, calendula, rosemary, peppermint, myrrh, frankincense, helichrysum and aloe; anda carrier in which each of said at least three plant extracts are dissolved or suspend.2. The topical composition of claim 1 , wherein said at least three plant extracts are four plant extracts.3. The topical composition of claim 1 , wherein said at least three plant extracts are five plant extracts.4. The topical composition of claim 1 , wherein said at least three plant extracts are six plant extracts.5. The topical composition of claim 1 , wherein said at least three plant extracts are seven plant extracts.6. The topical composition of claim 1 , wherein said at least three plant extracts are eight plant extracts.7. The topical composition of wherein each of said at least three plant extracts is present in an amount of from 0.1 to 60 total weight percent of an inventive composition claim 1 , with the total amount of plant extracts being between 2 and 90 total weight percent.8. The topical composition of wherein ...

Device for diffusing a prescribed mist specific to a user's emotional mental state Rx diffuser

Disclosed is a device and method for diffusing a therapeutic specific to a user's emotional/mental state (EMS), comprising the steps of: selecting (or assessing) at least one EMS, said selected (or assessed) EMS indicating at least one of an emotion, mental, and/or physical state of the user; and activating the ultrasonic membrane of the at least single reservoir (optionally, a plurality of reservoirs) housing the mist specific to the selected/assessed EMS, wherein said activation results in a vibration of the membrane causing an ultra-sonic frequency resulting in the atomization and diffusion of the prescribed mist based on the user-selected (or assessed) EMS. 1. A device for diffusing a therapeutic specific to a user's emotional/mental state (EMS) , said device comprising of:a housing;a reservoir bank within said housing, wherein said bank comprises a plurality of reservoirs;each reservoir comprising an ultrasonic membrane at one end and a diffusion pathway at the opposing end coupled to a diffusion outlet;a mist prescriber;a processor coupled to a memory element with instructions, said processor when executing said memory-stored instructions, configure the device to allow:a user-selected or system-assessed EMS specific to the user, said selected/assessed EMS indicating at least one of an emotion, mental, and/or physical state of the user; andthe mist prescriber activating the ultrasonic membrane of the reservoir housing the mist specific to the selected/assessed EMS, wherein said activation results in a vibration of the membrane causing an ultra-sonic frequency resulting in the atomization and diffusion of the prescribed mist based on the selected/assessed EMS.2. The device of claim 1 , wherein the EMS selected by the user is categorized as at least one of Dopamine claim 1 , Serotonin claim 1 , Epinephrine claim 1 , Norepinephrine claim 1 , Endorphin claim 1 , Acetylcholine claim 1 , Oxytocin claim 1 , or GABA neurotransmitters (NT).3. The device of claim 1 , ...

POWDER FOR DELIVERY TO THE ORAL CAVITY

A powder for delivery to the oral cavity of a user is disclosed. The powder includes at least two populations of particles. A first population of particles includes a stimulant, and a second population of particles includes a flavorant. Also described is a cartridge containing the powder for use in an inhaler device and inhaler device containing the powder. 1. A powder for delivery to the oral cavity of a user comprising:at least two populations of particles, wherein a first population of particles comprises a stimulant, and a second population of particles comprises a flavorant.2. A powder according to claim 1 , consisting of three claim 1 , four claim 1 , five claim 1 , or six populations of particles.3. A powder according to claim 1 , wherein the sensations provided by the at least two populations of particles demonstrate different rates of at least one of perception or duration.4. A powder according to claim 1 , wherein the mean particle size of one of the populations of particles is less than 50% of the mean particle size of a different population of particles.5. A powder according to claim 4 , wherein one population of particles has a mean particle size of 7-350 μm claim 4 , and a different population of particles has a mean particle size of 350-750 μm.6. A powder according to claim 1 , wherein the first population of particles has a smaller mean particle size and comprises a stimulant claim 1 , and the second population of particles has a larger mean particle size and comprises a flavorant claim 1 , and wherein the stimulant is capable of being perceived quickly by the user and taking effect rapidly claim 1 , and the flavorant is capable of being perceived later and persisting for a longer duration.7. A powder according to claim 1 , wherein at least one of the particle populations comprises a tobacco extract.8. A powder according to claim 1 , wherein the stimulant comprises nicotine claim 1 , caffeine claim 1 , theophylline claim 1 , or theobromine.9. A ...

Uses of mentha essential oil

A method for at least one of inhibiting obesity, preventing metabolic syndrome associated with obesity, treating neurodegenerative disease, preventing neurodegenerative disease, treating cardiovascular disease, preventing cardiovascular disease, treating type 2 diabetes, preventing type 2 diabetes, ameliorating sleep disturbance, regulating sleep, helping fall asleep, inhibiting inflammation, treating cancer and preventing cancer is provided, wherein the method comprises administering to a subject in need an effective amount of Mentha essential oil. A method for helping reduce the production of free radical is also provided, wherein the method comprises administering to a subject in need an effective amount of Mentha essential oil.

SKIN SENSITIZER DELIVERY SYSTEM

A skin-sensitizing formulation is provided in an edible, softgel pill. A person engaged in a sexual activity bites down on the pill, thereby effectuating the oral release of the skin-sensitizing formulation. This allows the skin-sensitizing formulation to be spread to a sexual partner, on any part of the skin or sexual region of the body preferably through oral contact with the partner. The skin-sensitizing substance is spread to the partner directly on the skin or through oral contact or beneath a condom worn by the partner. The skin-sensitizing formulation may include an essential mint oil, analog or derivative, and may further includes an enhancer, rubefacient, counterirritant, anesthetic, k-opioid receptor activator, or TRPM8 activator. Various inactive ingredients are also disclosed. 1. A method of delivering a skin-sensitizing substance , comprising the steps of:providing a skin-sensitizing formulation in an edible, softgel pill;biting down on the pill to effectuate the oral release of the skin-sensitizing formulation; andspreading the skin-sensitizing formulation to a sexual partner through oral contact.2. The method of claim 1 , wherein the skin-sensitizing formulation includes an essential mint oil.3. The method of claim 1 , wherein the skin-sensitizing formulation includes mentha piperita.4. The method of claim 1 , wherein the skin-sensitizing formulation includes menthol.5. The method of claim 1 , wherein the skin-sensitizing formulation includes cinnamon oil.6. The method of claim 1 , wherein the skin-sensitizing f01mulation includes cornmint oil.7. The method of claim 1 , wherein the skin-sensitizing formulation includes eucalyptus oil.8. The method of claim 1 , wherein the skin-sensitizing formulation includes citronella oil.9. The method of claim 1 , wherein the skin-sensitizing formulation includes camphor oil.10. The method of claim 1 , wherein the skin-sensitizing formulation further includes an enhancer claim 1 , rubefacient claim 1 , ...

Compositions of medium chaintryglycerides (MCT) and plant-based nutrients for brain health

A formulation that relates to enhancement of metabolic energy pathways to improve attention, cognitive, memory, analytical and executive functions of the human brain. The formulation comprising at least one medium chain triglyceride, at least one polyphenolic-rich phytonutrient, at least one brain carotenoid antioxidant, at least one dietary vitamin and mineral, and at least one nutrient, and mixtures and combinations thereof. 1. A formulation consisting of at least one triglyceride , at least one polyphenolic-rich phytonutrient , at least one brain carotenoid antioxidant , at least one dietary vitamin and mineral , at least one nutrient , at least one preservative , at least one flavoring agent and mixtures and combinations thereof , said triglyceride is selected from a group consisting of MCT oil , ketone esters , and coconut oil extracts , and mixtures and combinations thereof , said polyphenolic-rich phytonutrient is selected from a group consisting of spearmint , citrus flavonoids , Grape seed , Tea , and mixtures and combinations thereof , brain carotenoid antioxidant is selected from a group consisting of Lutein , Zeaxanthin , Meso-zeaxanthin , Natural mixed carotenes , and mixtures and combinations thereof , dietary vitamin and mineral is selected from a group consisting Vitamin B3 , Nicotinamide riboside , Vitamin C , Vitamin E , Zinc , Copper , and mixtures and combinations thereof , said nutrient is selected from a group consisting of Fatty acids , E-polylysine , Acacia gum , Sodium citrate , Smoothenol-3108 , glycosides , Citric acid and mixtures and combinations thereof.2. (canceled)3. (canceled)4. (canceled)5. (canceled)6. (canceled)7. The formulation of wherein said triglycerides comprise 15 gms of MCT oil claim 1 , 25 gms of ketone esters claim 1 , and 25 gms of coconut oil extracts.8. The formulation of wherein said polyphenolic-rich phytonutrients comprise 900 mg of spearmint claim 1 , 1000 mg of citrus flavonoids claim 1 , 250 mgs of Grape seed ...

Fragrance compositions comprising essential oils and products comprising same for reducing fatigue and improving brain function

The present technology generally relates to fragrance compositions comprising essential oils and products comprising the same. The present technology also relates to methods of using the fragrance compositions to reduce fatigue and improve executive brain function.

COMPOSITION FOR TREATING ALOPECIA AND METHODS OF MAKING AND USING THE SAME

The present disclosure relates to topical compositions for treating alopecia and methods of making and administering such compositions. In some embodiments, the topical composition can include a mixture of an aloe vera extract, glycerin, a castor oil, methylsulfonylmethane, biotin, or mixtures thereof. Benefits of the compositions and methods of treatment can include normal regrowth of hair. 1. A topical composition for treating alopecia comprising:a mixture of a first substance and a second substance,wherein the first substance includes an aloe vera extract, andwherein the second substance includes glycerin, a castor oil, methylsulfonylmethane, biotin, or mixtures thereof.2. The topical composition of claim 1 , wherein the second substance includes glycerin claim 1 , a castor oil claim 1 , or mixtures thereof.3. The topical composition of claim 1 , wherein the second substance includes glycerin.4. The topical composition of claim 1 , wherein the second substance includes the castor oil.5. The topical composition of claim 1 , wherein the first substance is contained in an amount of from about 0.1 volume percent to about 80 volume percent based on a total volume of the mixture.6. The topical composition of claim 1 , wherein the second substance is contained in an amount of from about 0.1 volume percent to about 80 volume percent based on a total volume of the mixture.7. The topical composition of claim 1 , wherein the first substance and the second substance are contained in a volume ratio of from about 2:1 to about 1:4.8. The topical composition of claim 1 , further comprising a third substance selected from the group consisting of an olive oil claim 1 , an alkaline water claim 1 , a grape seed oil claim 1 , an avocado oil claim 1 , a rosemary oil claim 1 , a grape fruit oil claim 1 , a myrrh claim 1 , a frankincense oil claim 1 , a lavender oil claim 1 , a peppermint oil claim 1 , a sweet almond oil claim 1 , a safflower seed oil claim 1 , a borage seed oil claim 1 ...

Tea Composition For Oral Administration

This invention concerns an enhanced green tea based product for oral use whereby the nutritional and health benefits of green tea, and additives which shall include some combination of flavoring, preservatives, caffeine, humectants, and water, can be ingested and absorbed by the user. 110.-. (canceled)11. An composition , comprising:{'i': Camellia sinensis, Camellia sinensis', 'sinensis', 'Camellia sinensis', 'assamica', 'Cannabis sativa, 'plant material comprising material from one or more of flowers, leaves, stems, seeds, and roots, tea, green tea, white tea, yellow tea, oolong, black tea, and any plant material harvested from var. and/or var. (tea), and/or (marijuana);'}a water content of 0-50 wt % and a water activity of less than 0.9;one of more humectants selected from the group consisting of Zemea® USP propanediol, glycerol, sorbitol, and polydextrose;NaCl1214-. (canceled)15Cannabis sativa.. The composition according to claim 11 , in which the plant material comprises material from16Cannabis sativaCamellia sinensis. The composition according to claim 11 , in which the plant material comprises at least one of and (e.g. tea claim 11 , green tea claim 11 , white tea claim 11 , yellow tea claim 11 , oolong claim 11 , black tea).1764.-. (canceled)65. A composition claim 11 , comprising:{'i': 'Camellia sinensis, Cannabis sativa', '5 wt % to 95 wt % of a plant material harvested from one or more of , yerba mate, a peppermint, a peppermint leaf and a peppermint leaf power;'}0.25 wt % to 25 wt % of a green tea extract;up to 70 wt % of one or more of a monk fruit extract, sodium gluconate, a lemon juice powder, a natural flavor; and a honey powder; andsaid composition having water in a range of from 0 wt % to 10 wt %.6680.-. (canceled)81. A composition claim 11 , comprising:a tea;at least one of a CBD and a THC;at least one of a sweetener and a flavor;wherein said composition is free of a nicotine; andwherein said composition is free of a tobacco.82. The composition of ...

NON-PRESCRIPTION MOTION SICKNESS MEDICATION CONTAINING AN ANALGESIC, AN H2 BLOCKER, AND AT LEAST ONE ANTACID

The present invention provides a compounded non-prescription medication for the treatment of motion sickness. The medication comprises: at least one analgesic selected from the group consisting of acetaminophen, ibuprofen, naproxen and salicylates; at least one histamine H-receptor antagonist selected from the group consisting of nizatidine, famotidine, cimetidine, ranitidine. famotidine; and at least one antacid selected from the group consisting of calcium carbonate, sodium bicarbonate, magnesium hydroxide, aluminum hydroxide, and bismuth subsalicylate. The medication may optionally comprise at least one additional ingredient selected from the group consisting of spearmint extract and ginger extract. The formulations are consistent in their effectiveness and devoid of the side effects of drowsiness and dry mouth. A presently preferred embodiment of the medication comprises primarily of ibuprofen, famotidine, calcium carbonate, magnesium hydroxide, spearmint extract and ginger extract. 1. A compounded non-prescription medication for the treatment of motion sickness comprising:at least one analgesic selected from the group consisting of ibuprofen, acetaminophen, naproxen and salicylates;{'sub': '2', 'at least one histamine H-receptor antagonist; and'}at least one antacid.2. (canceled)3. The compounded non-prescription medication of claim 1 , wherein said at least one antacid is selected from the group consisting of calcium carbonate claim 1 , sodium bicarbonate claim 1 , magnesium hydroxide claim 1 , aluminum hydroxide claim 1 , and bismuth subsalicylate.4. The compounded non-prescription medication of claim 1 , wherein said at least one histamine H-receptor antagonist consists primarily of famotidine claim 1 , and said at least one antacid consists primarily of calcium carbonate and magnesium hydroxide.5. (canceled)6. The compounded non-prescription medication of claim 4 , wherein the analgesic is primarily ibuprofen having a mass within a range of about 180 mg to ...

HERBAL SUPPLEMENTS AND METHODS OF USE THEREOF

In one embodiment, the present application provides an herbal supplement and method for treating bloating, constipation and/or weight gain in a human subject comprising orally administering to a subject in need thereof an effective amount of the herbal supplement comprising a red quebracho extract. In other embodiments, the supplement may additionally include a triterpenoid saponin, an anti-spasmodic agent, or both. 1. A method for treating bloating , constipation and/or weight gain in a human subject , comprising:orally administering to a human subject in need thereof an herbal supplement comprising condensed tannins in an amount effective to reduce bloating, constipation and/or weight gain in a human subject.2. The method of claim 1 , wherein the condensed tannins are administered from a red quebracho extract in the herbal supplement.3. The method of claim 2 , wherein the herbal supplement further comprises an herbal composition comprising an anti-spasmodic agent.4. The method of claim 3 , wherein the anti-spasmodic agent is provided in the form of a peppermint oil.5. The method of claim 2 , wherein the herbal supplement further comprises an herbal composition comprising a triterpenoid saponin.6AesculusSatindus. The method of claim 5 , wherein the triterpenoid saponin is provided in the form of an or species plant extract.7. The method of claim 5 , wherein the herbal supplement further comprises an herbal composition comprising an anti-spasmodic agent.8Aesculus hippocastanum. The method of claim 7 , wherein the herbal supplement is formulated in a dosage form that comprises between about 20 to 500 mg of red quebracho extract; between about 0.1 to about 2 mg of plant extract; and between about 0.05 to about 1 ml of peppermint oil.9. The method of claim 1 , wherein the herbal supplement further comprises a nutraceutically acceptable carrier.10. The method of claim 1 , wherein the human subject suffers from irritable bowel syndrome claim 1 , functional constipation ...

FOUNTAIN OF YOUTH - Steeped Herbal Anti-Bacterial Body Water For Consumption And Topical Use - The Thyme Lavender Oregano Mint Neem Solution For Acne, Eyelash And Pore Cleansing, Wrinkles, Body Odors, Breath Freshening, Vaginal Douching, Toenail Fungus, Blephritis, Comedones, Wound Care, And More...

This innovation is a unique, natural, CONSUMABLE and topical treatment for many of my body's ailments that has helped me in ways other products never did. The anti-bacterial herbs appear to fight the root cause of the many ailments listed, instead of just masking them. 1. (canceled)2. (canceled)3. A healthcare product comprising a solution derived from the oils or steeping of plant leaves of one or more of the plants thyme , oregano , lavender , mint , and neem for the application to the eyes , eye lashes , and eyelids for the well being of said areas , as a method for drainage of excessive and impacted eye mucus and comedones , wherein the solution is extracted in concentrations derived from steeping about one to one and one half tablespoons of each of the plant's leaves in about one cup of hot water. My Provisional Patent Number is 61/696,912 and this is the explanation of my product for my non-provisional patent application please.This innovation is a unique, natural, CONSUMABLE and topical treatment for many of my body's ailments that has helped me in ways other products never did. The anti-bacterial herbs appear to fight the root cause of the many ailments listed, instead of just masking them.It not only cleansed my pores for acne, but I used it both in and on my eyes, using a spray, although an eyedropper form would work, too. It gently allowed sebaceous debris, often called eye mucous, to painlessly ooze away from eyelash pores and other eye glands like NO other product I have heard of. It appears to unclog the micro eyelid circulation greatly reducing the puffiness we all get with age. It appears to cleanse pores, allowing the skin circulation to improve, healing itself better, reducing wrinkles and even my acne scars.By naturally killing bacteria that cause odors under your arms and orally, it has greatly improved my body odors. Because it is consumable, it works safely all the way down the back of the tongue where scrappers and chemical washes can't reach. ...

System and Method for Natural Hair Loss Prevention Oil

A first composition of essential oils, including 0.3% each of cedarwood, lavender, rosemary, thyme, and peppermint essential oils are thoroughly combined until evenly distributed. A second composition of oils are thoroughly combined, including 9.85% jojoba oil, 9.85% argan oil, and 78.79% grapeseed oil until evenly distributed. The first composition of essential oils is gradually stirred into the second composition of oils, producing a combined oil composition. The scalp is coated with the resulting combined oil composition, followed by massaging the oil composition into the scalp with kneading, squeezing and pinching motions, for 1-3 minutes and subsequently maintaining the oil mixture on the scalp for at least 30 minutes. 1) A composition for treatment and/or prevention of hair loss comprised of:cedarwood essential oil, lavender essential oil, rosemary essential oil, thyme essential oil, peppermint essential oil, jojoba oil, argan oil, and grapeseed oil.2) A composition for treatment and/or prevention of hair loss comprised of:a mixture of essential oils including 0.3-5% cedarwood essential oil, 0.3-5% lavender essential oil, 0.3-5% rosemary essential oil, 0.3-5% thyme essential oil, and 0.3-5% peppermint essential oil, anda base oil mixture of 9.85-16.85% jojoba oil, 9.85-16.85% argan oil, and 68.79-88.79% grapeseed oil.3) The composition of claim 2 , wherein said essential oil mixture is mixed independently until said oils of said mixture are evenly distributed and said base oil mixture is mixed independently until said oils of said base oil mixture are evenly distributed claim 2 , andwherein said essential oils mixture is further mixed gradually into said base oil mixture.4) The composition of claim 2 , wherein the composition is used to coat a user's scalp claim 2 , and said oil composition is kneaded into said scalp with squeezing and pinching motions claim 2 , for 1-3 minutes claim 2 , and allowed to remain on said scalp for at least 30 minutes.5) A ...

UCP-1 Expression Promoter

It is intended to provide a drug, a quasi-drug, a dermatological preparation for external use, or a material to be contained to drugs, quasi-drugs, dermatological preparations for external use, food products, or the like which has an excellent UCP-1 expression-promoting action and promotes conversion of adipose to brown adipose (browning). The present invention provides a UCP-1 expression promoter comprising a PPARγ activator and a Smad3 inhibitor in combination. The present invention also provides a UCP-1 expression promoter comprising a PPARγ activator, a Smad3 inhibitor, and a β3 adrenaline receptor activator or a TGR5 activator in combination. 17.-. (canceled)8. A UCP-1 expression promoter , a promoter of conversion to brown adipose , an energy consumption promoter , a body fat accumulation inhibitor , a preventive or ameliorative agent for obesity , a preventive or ameliorative agent for diabetes mellitus , or a preventive or ameliorative agent for hyperlipidemia , comprising rosiglitazone or pioglitazone as a PPARγ activator , and comprising SIS3 as a Smad3 inhibitor , as active ingredients.9. A method for promoting UCP-1 expression , a method for promoting conversion to brown adipose , a method for promoting energy consumption , a method for inhibiting body fat accumulation , a method for preventing or ameliorating obesity , a method for preventing or ameliorating diabetes mellitus , or a method for preventing or ameliorating hyperlipidemia , comprising ingesting or administering a PPARγ activator and a Smad3 inhibitor in combination , or combining an ingestion or administration of a PPARγ activator with a treatment for inhibiting Smad3.10. (canceled)11. The method according to claim 9 , wherein the PPARγ activator is rosiglitazone or pioglitazone claim 9 , and the Smad3 inhibitor is SIS3.12. The method according to claim 9 , wherein the PPARγ activator is any one or more selected from the group consisting of rosiglitazone claim 9 , pioglitazone claim 9 , ...

ANTIMICROBIAL & ANTIVIRAL COMPOSITION

A method of reducing the number of microorganisms entering the nose and proliferating in the nasal cavity including application of a solution of an antimicrobial, antiviral and antifungal composition to the anterior vestibular region of the nares. The antimicrobial, antiviral and antifungal solution includes ethyl alcohol as an active ingredient. Various embodiments may also include one or more of the following additional ingredients: orange oil; coconut oil; soy oil; emu oil; grapefruit seed extract; glycine soja; simmondsia chinensis (Jojoba); lauric acid; chlorhexidine gluconate; ginger oil; lavender oil; peppermint oil; spearmint oil; aloe oil; and a preservative, such as benzalkonium chloride and vitamin E. 1. A method of reducing the number of microorganisms entering the nose and proliferating in the nasal cavity of a human in need thereof consisting essentially of administering to said human's nose an applicator with a composition consisting essentially of ethanol and a component selected from the group consisting of orange oil , jojoba oil , vitamin E , coconut oil , benzalkonium chloride , lauric acid , chlorhexidine gluconate , ginger oil , lavender oil , peppermint oil , spearmint oil and aloe oil , wherein said number of microorganisms are reduced from entering the nose of the human.2. The method of claim 1 , wherein the applicator is a porous tip for delivering the composition to the human's nose.3. The method of claim 1 , wherein the applicator is a porous tip and a breakable glass ampoule.4. The method of claim 1 , wherein the applicator is a flocked swab.5. The method of claim 1 , wherein the applicator is a cotton swab.6. The method of claim 1 , wherein the applicator is a human finger.7. The method of claim 1 , wherein the applicator is a device structured to hold the composition and apply the composition to the inner surface of the nostril openings of the human's nose. This patent application is a Continuation-In-Part (CIP) of patent application ...

COMPOSITIONS, MEANS AND METHODS FOR A NOVEL INSECT REPELLENT

An insect repellent composition for repelling insects from mammals and vegetation. This composition comprises: dihydroxyacetone (DHA) and a carrier suitable for insect repellent compositions. DHA is the active ingredient and the composition is efficacious in repelling insects. 2. The composition of claim 1 , wherein said mammals are humans or animals.3. The composition of wherein said plants are selected from a group consisting of: tobacco claim 1 , cannabis claim 1 , or organically grown fruits and vegetables for human and animal consumption.4. The composition of claim 1 , wherein the concentration of DHA is in the range of 0.5% to 50% (% wt)5. The composition of claim 1 , wherein said composition is in a form selected from a group consisting of liquid claim 1 , aerosol claim 1 , lotion claim 1 , cream claim 1 , gel claim 1 , foam claim 1 , shampoo claim 1 , solid and any combination thereof.6. The composition of claim 1 , wherein said composition is suitable for topical use.7. The composition of claim 1 , wherein said composition is suitable for spatial use.8. The composition of claim 1 , wherein said insects comprise at least one selected from a group consisting of: mosquitos claim 1 , fleas claim 1 , ants claim 1 , sand flies claim 1 , spiders claim 1 , aphids claim 1 , tobacco moths and head-lice.9. The composition of claim 1 , wherein said composition additionally comprises at least one compound selected from the group consisting of water claim 1 , ethanol claim 1 , emulsifiers claim 1 , preservatives claim 1 , emollients claim 1 , humectants claim 1 , oils claim 1 , surfactants claim 1 , waxes claim 1 , solvents claim 1 , rheology modifiers claim 1 , suspending agents claim 1 , thickeners claim 1 , oils claim 1 , buffering agents claim 1 , chelating agents claim 1 , pH adjusters claim 1 , chelates claim 1 , perfumes claim 1 , brighteners claim 1 , and any combination thereof.10. The composition of claim 1 , further comprising a Maillard reaction inhibitor ...

Powdered plant preparation, the manner in which it is obtained, microgranules and tablets obtained from that preparation and the ways of producing them

Disclosed is a powdered plant preparation and a method for its preparation, as well as microgranules and tablets obtained therefrom, and methods for their preparation. The invention is suitable for use in the production of herbal preparations.

COMPOSITIONS FOR TREATING INFECTIONS

The present invention relates to compositions and in particular to compositions for treating a skin or mucosal membrane infection. 1. A composition for treating a skin or mucosal membrane infection , the composition comprising:glycerol;at least one surfactant;an alcohol;a terpene or terpenoid compound; anda copper compound.2. The composition of wherein the terpene or terpenoid compound is present in or extracted from an essential oil.3eucalyptus. The composition of wherein said essential oil is obtained from a camphor laurel tree claim 2 , a kapur tree claim 2 , a rosemary plant claim 2 , a mint plant claim 2 , a tree or a tea tree.4. The composition of wherein the terpene or terpenoid compound is camphor.5. The composition of wherein the terpene or terpenoid compound is menthol.6. The composition of wherein the copper compound is selected from the group consisting of copper gluconate claim 1 , copper carbonate claim 1 , copper sulphate claim 1 , copper chloride and copper salicylate.7. The composition of wherein the copper compound comprises copper sulphate.8. The composition of wherein the copper sulphate comprises copper sulphate pentahydrate.9. The composition of wherein the alcohol comprises isopropyl alcohol.10Hypericum perforatum. The composition of further comprising extract.11Calendula officinalis. The composition of further comprising extract.12. The composition of further comprising aloe vera.13. The composition of further comprising vitamin E.14. The composition of wherein the at least one surfactant comprises polyethylene glycol.15. The composition of wherein the at least one surfactant comprises polysorbate 80.16. The composition of wherein the composition comprises substantially no water.17. A method of producing a composition claim 1 , the method comprising:i) combining glycerol and a copper compound to produce a glycerol solution;ii) dissolving a terpene or terpenoid compound in an alcohol to produce an alcohol solution;iii) combining the glycerol ...

NATURAL ESSENTIAL OIL COMPOSITION FOR RELAXING NERVES, SLEEPING WELL AND PREVENTING COLD AND FLU

The present invention provides a natural essential oil composition for relaxing nerves, sleeping well and preventing cold and flu. The composition comprises holy basil, lemongrass, patchouli, old coriander seeds, and tangerine peels, wherein the amount (wt %} of holy basil essential oil is about: 0.1% to about 60%; the amount (wt %) of lemongrass essential oil is about 0.1% to about 55; the amount (wt %) of patchouli essential oil is about 0.1% to about 30%; the amount: (wt %) of essential oil of old coriander seeds is about 0.1 to about 50% and the amount (wt %) of essential oil of tangerine peels is about 0.1% to about 50%. The composition of the present invention further comprises additional essential oils for further use purposes. The composition also comprises carrier oils and solvents for adjusting suit able concentrations of the composition. 1. A natural essential oil composition for relaxing nerves , sleeping well and preventing cold and flu comprising with the amounts of percentage by weight (wt %): holy basil essential oil is about 0.1% to about 60%; lemongrass essential oil is about 0.1% to about 55; patchouli essential oil is about 0.1% to about 30%; essential oil of old coriander seeds is about 0.1 to about 50% and essential oil of tangerine peels is about 0.1% to about 50%.2. The natural essential oil composition of claim 1 , wherein the amount (wt %) of holy basil essential oil is about 0.1% to about 45; the amount (wt %) of lemongrass essential oil is about 0.1% to about 30%; the amount (wt %) of patchouli essential oil is about 0.1% to about 20%; the amount (wt %) of essential oil of old coriander seeds is about 0.1 to about 40% and the amount (wt %) of essential oil of tangerine peels is about 0.1% to about 30%.3. The natural essential oil composition of claim 1 , wherein the amount (wt %) of holy basil essential oil is about 0.1% to about 30%; lemongrass essential oil is about 0.1% to about 25%; patchouli essential oil is about 0.1% to about 15; ...

ORIENTAL MEDICINE COMPOSITIONS MARKED AS SEC 22 AND SEC 33 FOR IMPROVING CHILDREN'S UNDERWEIGHT, LOW GROWTH AND DEPRESSED RESPIRATORY ORGAN

The present invention relates to oriental medicine compositions marked as SEC 22 and SEC 33 for improving digestive functions and respiratory functions for improving children's underweight, low growth and depressed respiratory organ, an oriental medicine derived therefrom, and methods of preparing them. According to an example of the present invention, the oriental medicine composition containing broiled fruit of , broiled root of , dried peel of , broiled sprout of , broiled fruit of , root of , dried fruit of , and horn of 1. An oriental medicine composition for improving digestive functions and respiratory functions , the oriental medicine composition comprising:{'i': 'Crataegus pinnatifida;', 'broiled fruit of'}{'i': 'Atractylodes japonica;', 'broiled root of'}{'i': 'Citrus unshiu;', 'dried peel of'}{'i': 'Hordeum vulgare;', 'broiled sprout of'}{'i': 'Amomum xanthioides;', 'broiled fruit of'}{'i': 'Zingiber officinale;', 'root of'}{'i': 'Zizyphi', 'dried fruit of ; and'}{'i': 'Cervus elaphus.', 'horn of'}2Crataegus pinnatifidaAtractylodes japonicaCitrus unshiuHordeum vulgareAmomum xanthioidesZingiber officinaleZizyphiCervus elaphus. The oriental medicine composition of claim 1 , wherein the oriental medicine composition comprises from about 22 weight % to about 26 weight % of the broiled fruit of claim 1 , from about 17 weight % to about 21 weight % of the broiled root of claim 1 , from about 12 weight % to about 16 weight % of the dried peel of claim 1 , from about 12 weight % to about 16 weight % of the broiled sprout of claim 1 , from about 7 weight % to about 11 weight % of the broiled fruit of from about 5 weight % to about 9 weight % of the root of claim 1 , from about 5 weight % to about 9 weight % of the dried fruit of claim 1 , and from about 1 weight % to about 5 weight % of the horn of claim 1 , with respect to the overall weight of the oriental medicine composition.3. The oriental medicine composition of claim 1 , further comprising at least one from ...

Use of botanical extracts for improving brain health through enhanced neurogenesis

The present invention relates generally to a method for improving brain health by orally administering a botanical extract composition in an amount effective to promote the neurogenesis process. More particularly, the present invention relates to using spearmint ( Mentha spicata L.) extracts in order to increase the rate of neurogenesis.

THERAPEUTIC COMPOSITIONS COMPRISING HERBAL EXTRACTS AND ESSENTIAL OILS FOR SMOKING AND VAPORIZATION

The present invention discloses therapeutic compositions comprising herbal extracts and essential oils for smoking and vaporization useful in the treatment of various symptoms and diseases. More particularly the invention relates to compositions comprising herbal extracts and essential oils capable of providing therapeutic benefits, which helps to improve conditions like cough, cold, pain, energy, relaxation, calmness, digestion, immune system disorders and neurological disorders etc. The invention further relates to methods for treating the same using the compositions of the invention. The invention also discloses method of formulating a blend of herbal COextracts and essential oils without the use of any type of synthetic carriers or residual solvent or synthetic chemicals, thus improving quality, safety and efficacy. 1. A therapeutic herbal composition for smoking and vaporization comprising one or more herbal COextracts in an amount of 1 to 20%; one or more COessential oils and/or essential steam distilled oils in an amount of 1 to 20% together with one or more fixed oils selected from the group consisting of flax seed oil , sesame seed oil , castor oil , sunflower oil , soyabean oil , safflower oil , corn oil , hemp oil , palm oil , and peanut oil , in an amount of 60 to 98% , wherein , the composition is essentially devoid of chemical carriers viz. , PEG , PG and Glycerin , for use in treating different disease conditions like cough , cold , pain , energy , relaxation , calmness , digestion , immune system disorder and neurological disorders.2Cinnamomum zeylanicumElettaria cardamomumCrocus sativusSantalum albumOcimum sanctumCurcuma longaZingiber officinaleApium graveolensMentha piperitaCinnamomum camphoraCelastrus paniculatusBoswellia serrataMyristicaValeriana WallichiiNardostachys jatamansi. The therapeutic herbal composition for smoking and vaporization according to claim 1 , wherein the one or more essential oils are selected from the group consisting of ...

POWDER MIXTURE COMPOSITION OF NATURAL MATERIALS FOR CONTROLLING DEFICIENCIES IN POLYPEPTIDE ALPHA AND BETA HEMOGLOBIN CHAINS

The embodiments herein provide a powdered composition of natural substances for controlling deficiencies in polypeptide alpha and beta hemoglobin chains and a diet plan for treating thalassemia patient. The composition comprises passargad powder, pars powder, purgative material, fumigation material, snuffing material, vinegar syrup and parsomash powder. The passargad powder is a stomach tonic and acts as anti-parasitic, anti-diarrheal, anti-dysentery, anti-bloating and anti-heartburn agents. The pars powder comprises sprouted grains for providing nutrition to cells. The purgative material is body purifier or detoxification agent and helps in motion and bowl movement. The vapor/fumigation material softens and reduces stickiness of sputum and removes sputum. The snuff helps in sneezing and removal of sputum. The vinegar syrup breaks down fat and removes toxins. The parsomash is an detoxification agent. The composition and dietary plan eliminates the need of bone marrow transplant, blood transfusion and defroxamin in thalassemia patients. 1. The powdered mixture composition for controlling deficiencies in polypeptide alpha and beta hemoglobin chains for treating thalassemia patient comprising:a passargad powder, and wherein the passargad powder comprises 60 grams of liquorice, 60 grams of caraway, 10 grams of anise, 10 grams of mint, and 10 grams of sweet anise;a pars powder, and wherein the pars powder is a mixture of sprouted grains and wherein the sprouted grains comprise a wheat germ, an oat, an alfalfa, a rice, a lentil, a bean, a vetch, a black grain, a spinach bud, a cress bud, a pea and a bean;a purgative material, and wherein the purgative material comprises a powdered mixture of 50 grams of senna leaves, 50 grams of rose, 50 grams of manna, 25 grams of absinthium, 25 grams of flax and 25 grams of marshmallow;a vapour/fumigation material, and wherein vapour/fumigation material comprises a powdered mixture of 350 grams of coriander, 25 grams of thyme, 25 grams ...

PHARMACEUTICAL COMPOSITION CONTAINING CHAMPIGNON EXTRACT AND PEPPERMINT AND METHODS OF USE THEREOF

Provided herein is a pharmaceutical composition and method for reducing intestinal pain and lessening foul-smelling stool and intestinal gas associated with large intestine disorders, comprising orally administering to a subject in need thereof an effective amount of the pharmaceutical composition comprising (i) champignon mushroom extract and (ii) peppermint or spearmint. The composition is formulated to provide controlled and/or delayed release of the active substances for specific efficacy in the large intestine. 1. An oral pharmaceutical composition for reducing intestinal pain and lessening foul-smelling stool and intestinal gas , comprising (i) champignon extract , and (ii) peppermint or spearmint ,wherein the champignon extract is present in the pharmaceutical composition in an amount between about 10% to about 90% by weight of the total composition,wherein the peppermint or spearmint is present in the pharmaceutical composition in an amount between about 10% to about 90% by weight of the total composition.2. The pharmaceutical composition of claim 1 , wherein the champignon extract is present in the pharmaceutical composition in an amount between about 20% to 80% claim 1 , or between about 40% to 60% claim 1 , by weight of the total composition.3. The pharmaceutical composition of claim 1 , wherein the peppermint or spearmint is present in the pharmaceutical composition in an amount between about 20% to 80% claim 1 , or between about 40% to 60% claim 1 , by weight of the total composition.4. The pharmaceutical composition of claim 1 , wherein the champignon extract is provided in liquid or solid forms.5. The pharmaceutical composition of claim 1 , wherein the peppermint or spearmint is provided in forms including powders claim 1 , crystals claim 1 , extracts and oils.6. The pharmaceutical composition of claim 1 , wherein the oral composition is formulated for oral administration to provide controlled release of the active substances for specific local effect ...

INTAKING AN ANTIVIRAL BY INHALATION OR SPRAYING FOR RESPIRATORY TRACT INFECTION

Methods of treatment to inhibit or kill microorganisms (Bacteria or Virus) from infecting a respiratory tract of a human patient and to treat the respiratory tract when already infected by the microorganism are described. The method of treatment may include the step of administering a therapeutically effective dose of a treatment medication comprising eugenol to the patient via a nasal passageway into a respiratory system of the patient. Eugenol is found in clove oil, cinnamon oil, and other essential oils. Any one or more of these eugenol-containing oils may be used. 1. A method , comprising: administering a therapeutically effective dose of a treatment medication in a nasal passageway of the human patient to or kill the viruses, the treatment medication comprising eugenol as an active ingredient such that as the human patient breathes, the eugenol is drawn via a nasal passageway into the respiratory tract of the human patient, wherein the eugenol is an active ingredient', 'wherein a source of the eugenol as the active ingredient is either cinnamon oil or clove oil or a mixture of the cinnamon oil and the clove oil,', 'and wherein the treatment medication comprises at least 20% v/v concentration., 'administering an antiviral treatment by inhalation to kill viruses infecting a respiratory tract of a human patient, comprising24.-. (canceled)5. The method of claim 1 , wherein the step of administering the treatment medication comprising the eugenol comprises administering a combination of any two or more of the clove oil claim 1 , the cinnamon oil claim 1 , and other essential oils.6. (canceled)7. The method of claim 1 , wherein the step of administering the treatment medication comprises administering menthol.8. The method of claim 1 , wherein the step of administering the therapeutically effective dose includes providing the therapeutically effective dose via inhalation after spraying the treatment medication into the nasal passageway of the human patient.9. The ...

COMPOSITION FOR COOLING SKIN COMPRISING PHELLODENDRON BARK EXTRACT, METHOD OF PREPARING THE SAME, TOPICAL COMPOSITION COMPRISING THE SAME AND DERMATOLOGICALLY ACCEPTABLE CARRIER, AND METHOD OF COOLING SKIN BY APPLYING THE SAME

Provided are a composition for cooling skin comprising a Phellodendron bark extract, a method of preparing the composition, a skin-improving product comprising the composition and a method of cooling skin by applying the composition to a skin of a subject, wherein the skin needs cooling. The composition prevents a burning sensation in the skin and under the skin and reduces heat generated under the skin and on the skin. The composition includes a Phellodendron bark extract as a main ingredient and further includes an extract of one or more selected from the group consisting of Anemarrhena asphodeloides, Scutellaria baicalensis, Paeonia lactiflora, Dictamnus dasycarpus, Alumen, Dryobalanops aromatic and Mentha arvensis. 1. A method of preparing a plant extract comprising:(a) washing a plant with water, wherein the plant is Phellodendron bark; and(b) putting the washed plant and a first solvent at a volume ratio of 1:12 to 1:42 in a super fast low temperature vacuum extractor which contains a liquid phase extractor and a gas phase distillation part, and performing a vacuum extraction for 50-80 minutes at 60-80° C. to obtain a distillation solution in the gas phase distillation part and a liquid extract in the liquid phase extractor; and(c) optionally, removing the first solvent from the liquid extract to obtain a concentrated extract,wherein the distillation solution in (b) or the concentrated extract in (c) is the plant extract.2. The method according to further comprising:(d) adding Alumen to a second solvent in a volume ratio of 1:23 to 1:334 and performing a warm impregnation at 65-80° C. for 50-80 minutes and filtering to obtain a filtrate; and(e) mixing the filtrate of (c) with the distillation solution of (b) in a volume ratio of 5:1 to 1:1 (the distillation solution of (b): the filtrate of (d)) to prepare a stock solution,wherein the stock solution is the plant extract.3. The method according to claim 1 , wherein the first solvent is one or more selected from ...

SKIN SENSITIZER DELIVERY SYSTEM

A skin-sensitizing formulation is provided in an edible, softgel pill. A person engaged in a sexual activity bites down on the pill, thereby effectuating the oral release of the skin-sensitizing formulation. This allows the skin-sensitizing formulation to be spread to a sexual partner, on any part of the skin or sexual region of the body preferably through oral contact with the partner. The skin-sensitizing substance is spread to the partner directly on the skin or through oral contact or beneath a condom worn by the partner. The skin-sensitizing formulation may include an essential mint oil, analog or derivative, and may further includes an enhancer, rubefacient, counterirritant, anesthetic, k-opioid receptor activator, or TRPM8 activator. Various inactive ingredients are also disclosed. 1. A method of delivering a skin-sensitizing substance , comprising the steps of:providing a skin-sensitizing formulation in an edible, softgel pill;biting down on the pill to effectuate the oral release of the skin-sensitizing formulation; andspreading the skin-sensitizing formulation to a sexual partner through oral contact.2. The method of claim 1 , wherein the skin-sensitizing formulation includes an essential mint oil.3. The method of claim 1 , wherein the skin-sensitizing formulation includes mentha piperita.4. The method of claim 1 , wherein the skin-sensitizing formulation includes menthol.5. The method of claim 1 , wherein the skin-sensitizing formulation includes cinnamon oil.6. The method of claim 1 , wherein the skin-sensitizing f01mulation includes cornmint oil.7. The method of claim 1 , wherein the skin-sensitizing formulation includes eucalyptus oil.8. The method of claim 1 , wherein the skin-sensitizing formulation includes citronella oil.9. The method of claim 1 , wherein the skin-sensitizing formulation includes camphor oil.10. The method of claim 1 , wherein the skin-sensitizing formulation further includes an enhancer claim 1 , rubefacient claim 1 , ...

COMPOSITION FOR USE IN AROMATHERAPY, AROMA MEDICINE AND AROMATOLOGY

The present invention refers to a composition for aromatherapy, as well as to its use as a medicine and in aromatherapy for the treatment of troublesome emotions. The composition includes 0.01 to 0.125 vol-% of an active composition and 0.1 to 99.99 vol-% of a transport composition and optionally a carrier oil and/or an alcohol. The active composition contains a mixture of 80 to 120 different essential oils and an alcohol in a volume ratio of 1:500 to 1:5,000 of oils:alcohol. The transport composition is made of one or more essential oils. The treatment involves smelling of the composition simultaneously with a troublesome emotion. In this way, the emotion is sustainably relieved. 1. A composition for aromatherapy , comprising 0.01 to 0.125 vol-% of an active composition and 0.1 to 99.99 vol-% of a transport composition and optionally a carrier oil and/or an alcohol , whereinthe active composition contains a mixture of 80 to 120 different essential oils and an alcohol in a volume ratio of 1:500 to 1:5,000 of oils:alcohol,the transport composition consists of one or more, but no more than 35 different essential oils,the carrier oil is selected from the group consisting of avocado oil, calophyllum oil, hemp oil, St. John's wort oil, jojoba oil, coconut fat, macadamia nut oil, almond oil, evening primrose oil, olive oil, calendula oil, sallow thorn oil, black cumin oil, sesame oil, shea butter, grape seed oil, monk's pepper oil, wild rose oil, and mixtures thereof, andthe alcohol is selected from the group consisting of methanol, ethanol, propanol, and isopropanol, preferably ethanol.2. The composition according to claim 1 , wherein the active composition contains essential oils and alcohol in a volume ratio of 1:1 claim 1 ,000 to 1:2 claim 1 ,000 claim 1 , preferably in a volume ratio of 1:1 claim 1 ,300 to 1:1 claim 1 ,400 claim 1 , more preferably in a volume ratio of 1:1 claim 1 ,370 bis 1:1 claim 1 ,380 claim 1 , and in particular in a volume ratio of 1:1 claim 1 ...

DEVICES AND METHODS FOR TREATING EAR PAIN

The present invention relates generally to a methods and apparatuses for treating ear pain and clearing excess fluid from Eustachian tubes. 1. A method of treating ear pain , comprising: a handle; and', a first surface that is substantially flat and parallel to the handle;', 'a second surface that is substantially convex and configured to fit within an oral cavity of the user and to contact a roof of the oral cavity of the user;', isomalt;', 'citric acid;', 'xylitol;', 'vitamin C; or', 'lemon oil,, 'one or more of], 'a dissolvable composition attached to the handle, the dissolvable composition comprising, 'wherein, the dissolvable composition attached to the handle is configured to promote drainage of the fluid from the Eustachian tube of the user via a negative pressure formed within the oral cavity of the user., 'administering to a user an apparatus for promoting drainage of fluid from a Eustachian tube of the user, the apparatus comprising2. The method of claim 1 , wherein the dissolvable composition further comprises an internal analgesic substance.3. The method of claim 2 , wherein the internal analgesic substance comprises acetaminophen.4. A method of treating ear pain claim 2 , comprising: a handle; and', a salivary-producing substance;', 'a dietary supplement; and', 'an antimicrobial preservative,, 'a composition attached to the handle, the composition comprising, 'wherein, the composition attached to the handle is configured to promote drainage of the fluid from the Eustachian tube of the user via a negative pressure formed within an oral cavity of the user., 'administering to a user an apparatus for promoting drainage of fluid from a Eustachian tube of the user, the apparatus comprising5. The method of claim 4 , wherein the composition further comprises:a first surface that is flat and parallel to the handle; anda second surface that is convex.6. The method of claim 5 , wherein the second surface is configured to fit within the oral cavity of the user.7. ...

Method for Producing Articles of Plant Origin Impregnated With a Liquid Plant Substance

The present invention relates to a method for producing articles impregnated with at least one plant substance from at least one plant, characterized in that it comprises the following steps: 1. A method for producing articles impregnated with at least one plant substance from at least one plant comprising:{'b': 1', '1, 'a) Extraction and/or pressing of at least one plant (V), or at least one part of said plant, thereby producing a liquid plant extract (E) and a solid fibrous residue (RI), then'}{'b': 1', '1, 'b) Separation of said plant extract (E) from said fibrous residue (R), and'}{'b': '1', 'c) Destructuring of said fibrous residue (R),'}{'b': '1', 'd) Production of a fibrous web or of an article made from the fibrous residue (R) obtained in step c), and'}{'b': 1', '1', '1', '1', '2', '2', '2, 'e) Impregnation of said fibrous residue (R) with (i) at least said plant extract (E), which is optionally concentrated, purified, flavored and/or fragranced, with (ii) at least one water-soluble or liposoluble plant substance isolated from said plant extract (E), with (iii) at least one composition comprising at least one optionally concentrated, purified, flavored and/or fragranced water-soluble or liposoluble substance of said plant extract (E), or with (iv) at least one plant extract (E) or at least one composition comprising at least one optionally concentrated, purified, flavored and/or fragranced water-soluble or liposoluble substance of said plant extract (E), resulting from an extraction or pressing of a plant (V) different from said plant (VI).'}2. The method according to claim 1 , wherein steps c) claim 1 , d) and e) may occur in the following order:step c) precedes step d), which in turn precedes step e), orstep c) precedes step e), which precedes step d).3. The method according to claim 1 , wherein:the plant is chosen from among food plants, medicinal plants, aromatic plants and fragranced plants; or whereinthe plant is chosen from among plants containing at ...